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Abstract
Kiet Anh Tran
BIOENGINEERED SCAFFOLDS TO INDUCE ALIGNMENT AND PROMOTE
AXON REGENERATION FOLLOWING SPINAL CORD INJURY
2018-2022
Peter A. Galie, PhD
Doctor of Philosophy

Scaffolds delivered to injured spinal cords to stimulate axon connectivity often act
as a bridge to stimulate regeneration at the injured area, but current approaches lack the
permissiveness, topology and mechanics to mimic host tissue properties. This dissertation
focuses on bioengineering scaffolds through the means of altering topology in injectables
and tuning mechanics in 3D-printed constructs as potential therapies for spinal cord injury
repair. A self-assembling peptide scaffold, RADA-16I, is used due to its established
permissiveness

to

axon

growth

and

ability

to

support

vascularization.

Immunohistochemistry assays verify that vascularized peptide scaffolds promote axon
infiltration, attenuate inflammation and reduce astrogliosis. Furthermore, magneticallyresponsive (MR) RADA-16I injections are patterned along the rostral-caudal direction in
both in-vitro and in-vivo conditions. ELISA and histochemical assays validate the efficacy
of MR hydrogels to promote and align axon infiltration at the site of injury. In addition to
injectable scaffolds, this thesis uses digital light processing (DLP) to mimic the mechanical
heterogeneity of the spinal cord caused by white and gray matter, and demonstrate that
doing so improves axon infiltration into the scaffold compared to controls exhibiting
homogeneous mechanical properties. Taken together, this work contributes to advancing
the field of tissue engineering and regenerative medicine by demonstrating the potential of
bioengineered scaffolds to repair the damaged spinal cord.
v
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Chapter I
Introduction
Spinal cord injury (SCI) is a neurological disorder that stems from
mechanical forces that cause synaptic failure between axons that eventually lead to
neurodegeneration and ultimately result in permanent disabilities [1]–[3]. The primary
injury results in the death of neurons and cause the blood vessels to lose their blood-spinal
cord barrier [4]. Subsequently, inflammation caused by disruption of the barrier leads to
the formation of glial scars that prevent axons from regenerating into the injured area [2].
SCI affects approximately 17,730 new patients per annum, causing over 291,000
hospitalizations annually in the United States alone [5]–[9]. Despite the previous
therapeutic attempts to bridge the site of injury, glial scars present a physical barrier to
obstruct axon regrowth and the influx of microglia and reactive astrocytes provide a
biochemical barrier that becomes a hostile environment to prevent neuroregeneration [10].
This hostile environment is one of the major factors preventing neuronal regeneration and
subsequently an effective repair strategy for these pathologies. To encourage axon
regrowth, therapeutic strategies have attempted to attenuate glial scar formation through
the inhibition of glial fibrillary acidic protein (GFAP) which have been shown to
exacerbate the injury, suggesting that scarring exerts neurotropic properties even though it
inhibits neuronal regeneration [11], [12]. The prevalence and permanence of SCI create a
substantial public health issue, necessitating a strategy to restore function by instigating
axon regrowth and connectivity.
Current approaches to treat SCI rely heavily on pharmacological and activity-based
rehabilitation strategies that include neurotrophic factors to promote neuronal growth and
1

survival at the site of injury [13]–[15]. However, these approaches have proven to be
minimally effective due to the inability to restore axon connection and facilitate the
direction of regrowth in the presence of glial scars. In addition to preventing axon regrowth,
scars in the central nervous system are initially more compliant than the surrounding tissue
due to an altered extracellular matrix (ECM) composition [16]. The change in tissue
mechanics presents a blockage to inhibit axon regeneration that disrupt cell-matrix
interactions and mechanosensing between axons and the surrounding microenvironment.
Yet, none of these therapeutic strategies have shown to restore axon connectivity in human
patients.
Bioengineered scaffolds designed to treat spinal cord injury fall under two broad
categories: (i) injectable strategies and (ii) solid scaffolds. Transplantation of injectable
biomaterials is less invasive than pre-fabricated scaffolds because they can be delivered
through small-gauged needles; however, this delivery method precludes patterning
topologies that guide cell growth and motility. Although studies have altered fiber
orientation with magnetic fields in vitro [17]–[21], this approach has not been applied in
vivo. Yet, magnetic fields can penetrate beyond the range of light-based methods,
especially in tissues obstructed by bone including the spinal cord. Therefore, part of this
dissertation uses spinal cord injury as a model to determine whether a magnetic field can
align a self-assembling peptide hydrogel in the rostral-caudal direction following injection.
Overall, these results in this dissertation indicate that magnetism is a viable means to align
biomaterials post-injection.
Another approach to bridge the cavity of the spinal cord is to implant prefabricated
conduits that facilitate the growth of axonal processes across the site of damage provide
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the potential for a direct multifunctional treatment. A limitation of previous scaffolds is the
inability to fabricate scaffolds with complex topologies that have tunable mechanical
properties. Conduits featuring voids aligned in the rostral-caudal direction have been used
in models of spinal cord injury, but consist of materials with fixed mechanical properties
[22]. 3D-printing provides a means to precisely control the geometry and topology of
scaffolds, and has been used previously to repair spinal cord injury in small animal models
[23]. However, the scaffolds in that particular study exhibited an elastic modulus exceeding
200 kPa, which far surpasses the mechanical properties of the surrounding tissue and
precludes the ability to seed cells within the bulk of the scaffold. Our laboratory has helped
to pioneer a 3D-printing approach to print complex topologies within tunable 3D scaffolds
that overcomes the limitations of previous strategies [24]. This process can be used to
control and guide the growth of axons in scaffolds with tunable mechanical and
biochemical properties to facilitate both infiltration and outgrowth from the site of injury.
Specifying a microenvironment that overcomes the barrier created by the inflammation and
scarring caused by the injury provides an alternative strategy to instigate axon infiltration.
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Chapter II
Background
2.1. Vascularized Injectables as Potential Therapies for Spinal Cord Injury Repair
Bioengineered scaffolds hold tremendous potential for stimulating axon growth in
the aftermath of a spinal cord injury (SCI). The purpose of a scaffold is to bridge the
damaged spinal cord so that patients can experience functional recovery, and clinical trials
using scaffold transplantation have already begun [25]. Previously described strategies
include providing physical guidance cues for axon growth/regeneration [26], [27],
releasing neuroprotective or neuroregenerative growth factors [28], or delivering precursor
or support cells to the injury site [29]–[31]. However, as with many other endeavors
involving scaffold and cell transplantation, delivery of nutrients and oxygen to the injury
site remains a challenge. Axons regenerating into the scaffold require oxygen transport to
continue their growth, as do precursor cells seeded into the injury site. Moreover, a recent
study demonstrated that a pre-vascularized scaffold encouraged the growth and guided the
regeneration of host axons into a collagen-hyaluronan composite matrix following
transplantation [32]. These results validate that scaffold vascularization provides a
promising strategy to advance bioengineered scaffolds for SCI repair.
In the aftermath of SCI (7–10 days post-injury), a strong angiogenic response
mediated by VEGF and HIF1-α restores oxygen and nutrient transport to the site of injury
[33]–[35]. However, these nascent vessels initially lack a blood-spinal cord barrier (BSCB)
[36], and are thus unable to prevent the inflammation and reactive gliosis that exacerbate
the damage. Inflammation and scar formation represent the secondary aspect of SCI that
contributes to the inhibition of axon growth and functional recovery. Rat models of SCI
4

indicate that in the months following this initial angiogenic response, the density of the
vasculature significantly decreases as the tissue remodels [36]. Transplantation of
vasculature exhibiting a functional BSCB within a bioengineered scaffold can potentially
stabilize the vasculature within the cord and attenuate the inflammatory effects that inhibit
neuroregeneration.
RADA-16I, a peptide that forms a self-assembling hydrogel in response to pH, is
the main component of the scaffolds used in specific aim 1 and 2. The composition of
RADA16-I (Ac-RADARADARADARADA-CONH2) exhibits an appropriate structural
environment that supports the growth of axons following SCI [37] and minimizes glial scar
and inflammation in surrounding tissue [38]. Furthermore, studies have shown that the
scaffold exhibits biocompatibility with host tissue and causes minimal tissue inflammation
and immune response [39]–[42]. RADA-16I also provides a three-dimensional
environment that allows cells to grow, proliferate and migrate [41], [43]–[45]. Previous
studies have shown that not only can RADA-16I effectively treat intracerebral hemorrhage
[46], but this synthetic material is also capable of providing a favorable environment for
capillary morphogenesis [47], though microvessels with BSCB-integrity have yet to be
fabricated within RADA-16I prior to the studies within this dissertation. Overall, its
established ability to support vascularization and axon growth validates the use of RADA16I in the work in this dissertation.
2.2. Methods to Facilitate Rostral-Caudal Alignment in Injectables Post-Delivery
One benefit of regenerative scaffolds is the ability to provide a compatible matrix
with guidance cues to cells within and surrounding the scaffold. A common example of
this approach is provided by scaffolds and conduits delivered to the site of spinal cord
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injury; alignment in the rostral-caudal direction improves host axon infiltration and can
also mitigate secondary aspects of the injury including inflammation and glial scarring
[48]–[50]. Such guidance cues can be provided by cylindrical holes aligned in the axial
direction of the conduit [51]–[53]. Recent advances in 3D printing have been used to apply
this technique to geometries that match specific tracts within the spinal cord [54]. However,
scaffold alignment can also be implemented on the level of individual fibers, using
techniques that include electrospinning [55], [56] and the application of either interstitial
flow [32] or mechanical stretch [57], [58]. Previous work from our laboratories
demonstrated that transplanting scaffolds with aligned microvessels exerted a similar
benefit on guiding axon infiltration in a spinal cord injury model [32]. However, previously
described approaches are only compatible with pre-fabricated scaffolds: they are not
applicable to injectable hydrogels.
The primary advantage of injectable strategies for the treatment of spinal cord
injury and other pathologies is their minimal invasiveness compared to pre-fabricated
scaffolds. Injectable hydrogels can be delivered through small gauge needles, and mitigate
the damage to surrounding healthy tissue incurred by the transplantation of a solid-phase
scaffold. The majority of cell therapies in current clinical trials for the treatment of spinal
cord injury are delivered via injection [59], providing a framework for similar
transplantation with hydrogels. Furthermore, advances in self-assembling peptide
hydrogels have demonstrated the therapeutic potential of injectable scaffolds for a variety
of regenerative applications [37]–[39], [41]. Specifically, RADA-16I has been shown to
improve axon infiltration following central nervous system injury. Recently, our
laboratories demonstrated the benefit of injecting RADA-16I hydrogels seeded with
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microvascular cells for increasing axon infiltration and reducing inflammation and scarring
[60]. However, the limitation of RADA-16I and other self-assembling hydrogels is the
inability to control the orientation and topology of the fibrous matrix.
The regenerative potential of injectable hydrogels can be augmented by strategies
to tune physical guidance cues following delivery. Previous studies have described
methods to alter hydrogel structure following transplantation: photocrosslinkable
hydrogels such as PEGDA can be altered with the administration of ultraviolet light
following delivery [24], [61]. However, light-based approaches are limited by the depth
the scaffold is transplanted and whether the injury site is obscured by bone. Thus, a lightbased method to alter an injectable hydrogel is not an option for spinal cord regeneration
[62]. In contrast to UV and visible light, magnetic fields penetrate further into the body and
thus provide an option to tune hydrogel topology. Several in vitro studies have
demonstrated that seeding magnetic particles (MPs) into hydrogels and applying a
magnetic field prior to polymerization results in alignment of fibrous matrices [17]–[21].
However, these techniques have yet to be implemented as a strategy in vivo, despite the
potential to overcome the limitations of existing methods to alter hydrogels posttransplantation.
A goal in this dissertation is to assess magnetic alignment as a strategy to align
RADA-16I self-assembling hydrogels injected into a rat model for spinal cord injury.
Specifically, a contusion injury model is used to increase the clinical relevance of these
studies. The magnetically responsive (MR) scaffolds are combined with human
mesenchymal stem cells (hMSCs), which have shown encouraging results from ongoing
clinical trials [59]. In order to determine the parameters needed to align the fibrous
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network, initial in vitro experiments are conducted using hMSC-seeded peptide hydrogels
and rat-derived neural progenitor cells (NPCs) to replicate in vivo environments. The
magnetic parameters found to align the peptide hydrogels are subsequently extended to
proof-of-concept animal experiments for facilitating axon growth along the rostral-caudal
direction. Overall, these experiments evaluate magnetic alignment in both in vitro and in
vivo environments to determine its potential to align injectable hydrogels following
delivery.
2.3. Magnetic Particles to Dynamically Alter Viscoelastic Hydrogels
Our research indicated that applying magnetic fields to MR hydrogels provided the
capability to rapidly and reversibly tune their mechanical properties. Previous
understanding of how cells respond to the mechanics of their extracellular matrix (ECM)
has been traditionally informed by experiments using two-dimensional (2D) substrates
[63], [64]. These studies have demonstrated that cells alter their morphology [65], signaling
[66], and phenotype [67] based on the mechanical properties of polyacrylamide or
polydimethylsiloxane substrates to which they are attached. Yet, most non-epithelial cell
types are fully surrounded by their ECM, and 2D substrates are unable to capture this aspect
of the in vivo microenvironment. Alternatively, cells can be seeded within threedimensional (3D) hydrogels to mimic cell-ECM interactions. Studies using hydrogels have
identified multiple facets of the cell response that differ between 2D and 3D geometries
[68], [69]. However, in contrast to the linearly elastic substrates used for 2D
mechanotransduction studies, the mechanics of 3D hydrogels, especially those comprised
of natural proteins including collagen and fibrin, are complicated by viscoelastic and strain
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stiffening properties that have been shown to alter the cell response [70]–[73]. Nonetheless,
these properties are more representative of the mechanics of the ECM in vivo.
Although 3D hydrogels better mimic the geometry and mechanics of the ECM,
tuning the mechanical properties of these scaffolds is more difficult than 2D substrates.
Doing so dynamically is even more challenging. Currently, methods to alter the mechanics
of cell-seeded 3D scaffolds rely primarily on photocrosslinkable [74], [75] and
photodegradable [76], [77] chemistries. However, these approaches generally require
substantial modification of hydrogel chemistry and composition and cannot be reversibly
cycled through a broad range of mechanical properties. Moreover, cytotoxicity assays
reveal that cell viability significantly decreases as the concentration of photocrosslinkers
increases, limiting the possible range over which these substrates can be tuned. Studies
have found that altering the degradability of these hydrogels affects the cell response to the
mechanics of their surroundings, preventing direct interrogation of the effect of 3D
substrate stiffness [74]. These limitations necessitate a reversible and repeatable method to
modify hydrogel mechanics without changing the microstructure of the surrounding
fibrous matrix.
Magnetorheological materials containing carbonyl iron microparticles (MPs)
provide a means to overcome the limitations of previous methods to tune hydrogel
mechanics. These materials respond to external magnetic fields in a rapid, reversible, and
repeatable manner [78], [79]; their stiffness can substantially increase or decrease by
changing the strength of the magnetic field. This effect is dependent upon MP
concentration, demonstrating that greater changes can be achieved by adding more
magnetic particles [80]. Previous studies have used 2D substrates embedded with MPs to
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study cell mechanotransduction [78]. However, cells can also be embedded inside of
magnetorheological materials like kappa-carrageenan and N, N-dimethylacrylamide
(DMAAm) and laponite without a loss of viability [81], [82].
This dissertation evaluates the ability of MPs to dynamically tune the mechanical
properties of hydrogels consisting of natural proteins and proteoglycans, creating a method
is applicable to a broader range of scaffolds than previously described synthetic
magnetorheological materials. Here, scaffold mechanics are dynamically tuned by
submerging carbonyl iron MPs and applying an external magnetic field. Embedding 10
wt% MPs into a 5 mg/mL collagen scaffold with the application of 4,000-Oe magnetic
field drastically increases the storage modulus from approximately 1.5 kPa to 30 kPa. More
importantly, translating this approach to hydrogels containing proteins and proteoglycans
gives rise to a more physiologically-relevant platform to control cell morphology,
mechanosensing pathways, and calcium transients. The findings described in this work
demonstrate that magnetically-responsive hydrogels provide a new means to rapidly and
reversibly tune hydrogel mechanics to evaluate cellular mechanotransduction in 3D.
2.4. 3D-Printed Scaffolds for Spinal Cord Regeneration
Although injectable scaffolds are minimally invasive, 3D-printed scaffolds provide
the ability to alter topology and geometry to stimulate regeneration. A potential benefit of
transplanting bioengineered scaffolds is the delivery of a matrix with mechanical properties
that mimic the host tissue, but the mechanics of native tissue are often heterogeneous and
difficult to characterize. In particular, our understanding of the mechanical properties of
the central nervous system (CNS), specifically the spinal cord, has primarily been informed
by macroscale measurements [83]–[85]. These studies have shown that CNS mechanics
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are heterogenous via tensile, shear, compression testing [86], [87] and magnetic resonance
elastography [88], [89]. In order to supplement bulk approaches, atomic force microscopy
(AFM) has proven a useful tool to measure the stiffness of the spinal cord with higher
spatial resolution. However, published data are contradictory regarding the difference in
mechanical properties between white and gray matter [90]–[92]. Physiologically, white and
gray matter exhibit differences in cellular and matrix composition: white matter mainly
consists of glial cells and myelinated axons aligned along the rostral-caudal direction,
whereas gray matter is mostly comprised of neuronal cell bodies and glial cells, which
likely alters the macroscale mechanical properties. Moreover, the complex and variable
environment of a spinal cord injury (SCI) is known to alter cord mechanics [16]. Therefore,
transplanting a scaffold that mimics the mechanical heterogeneity of white and gray matter
may improve axon infiltration at the site of spinal cord injury.
Bioengineered scaffolds with a wide array of mechanical properties have
previously been used in spinal cord injury. The overall goal of transplanted hydrogels or
conduits is to bridge the injured area by facilitating axon connectivity and eventual
functional recovery for patients. Previously used scaffolds in animal studies and human
clinical trials incorporate a wide variety of biomaterials including collagen [32],
polycaprolactone [93]–[96], electrospun fibers [97]–[99], fibrin [100]–[102] and can either
be injected [60], [103] or delivered as solid conduits [32]. These approaches use several
repair strategies including delivery of neurotrophic factors or cells [104], implementation
of a conductive microenvironment using electrically active materials [105], and providing
guidance cues by anisotropic topologies including cylindrical voids [94], [106], [107].
Considerations for biomaterials used in previous spinal cord scaffolds include
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biocompatibility, degradability, and premissivity to infiltrating axons from the host. Yet,
none of the previous approaches tune the mechanical heterogeneity within the construct as
a potential repair strategy for spinal cord regeneration.
3D-printed scaffolds provide a means to fabricate heterogeneous mechanical
properties that match native spinal cord tissue. Previous approaches have demonstrated that
photocrosslinkable hydrogels can be used in 3D-printed systems that can mimic the
anisotropy of various tissues including skeletal muscle [108], bone [109]–[111], cartilage
[112]–[115], and neural tissue [116], [117]. 3D-printing has been used to fabricate spinal
cord conduits that feature voids aligned in the rostral-caudal to mimic specific axon tracts
[23]. However, the scaffolds in that particular study exhibited an elastic modulus exceeding
200 kPa, which far surpasses the mechanical properties of the surrounding spinal cord
tissue and precludes the ability to differentiate between the stiffness of white and gray
matter. Recent innovations in 3D-printing approach, specifically digital light printing
(DLP) have been used to create complex topologies within tunable 3D scaffolds that
overcomes the limitations of previous strategies [24], [118]. This process can be used to
control and guide the growth of axons in scaffolds with heterogeneous mechanical
properties to facilitate both infiltration and outgrowth from the site of injury. In this work,
an array of macroscale and microscale mechanical tests are used to characterize the
mechanical properties of native spinal cord tissue, and then use DLP to mimic the
mechanical heterogeneity in transplantable scaffolds.
2.5. Hypothesis and Specific Aims
This dissertation describes the potential for both injectable and solid scaffolds to
stimulate central nervous system (CNS) regeneration by providing biophysical guidance
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cues for host axons. These two categories have tremendous potential to create biomaterials
or constructs that stimulate neuronal regeneration, but there are few examples of exploiting
this technology for CNS applications. Previous approaches have yet to alter topologies on
the individual fiber level to facilitate cell growth in vivo and fabricate mechanical
heterogeneity in 3D-printed constructs to promote neuronal regeneration. In addition to
delivering these biomaterials to the site of injury, cells can be transplanted into the bulk of
these constructs (both injectable and 3D-printed scaffolds) to provide neurotropic
properties that will instigate neuronal regeneration. Therefore, the approaches described in
this dissertation not only bolsters scaffold-based therapeutics for transplantation, but also
increases the capability of cell-based therapies to provide neurotropic factors delivered to
the site of injury.
The spinal cord is a unique tissue to test the functionality of implanted biomaterials
in the central nervous system because of its anisotropic axon topology. Previous strategies
reveal that alignment in the rostral-caudal direction provides functional benefits by
encouraging infiltration and reconnecting axons following spinal cord injury (SCI).
However, less is known about the potential benefits of vascularized scaffold to induce axon
infiltration, altered topology along the rostral-caudal direction in injectables post-delivery,
and mechanical properties on neuronal infiltration and outgrowth. To date, the initial
indicator of regeneration relies on alignment in the rostral-caudal direction to improve host
axon infiltration that can also mitigate secondary aspects of the injury including
inflammation and glial scarring. The specific aims of this dissertation seek to design and
fabricate bioengineering scaffolds that induce alignment and promote axon infiltration
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following spinal cord injury. The following aims will be used to test the hypothesis and
interrogate the benefits of both injected and transplanted scaffolds on neuroregeneration.
2.6. Research Aims
Aim 1: Evaluate axon infiltration and secondary injury following delivery of
vascularized injectable hydrogels in contusion spinal cord injury model. The experiments
conducted in this aim will examine the effectiveness of implanting injecting scaffolds with
blood-spinal cord barrier (BSCB)-integrity microvessels to augment and facilitate axon
infiltration. Vascularized self-assembled peptide scaffolds will be administered at the site
of a rat model of a cervical contusion spinal cord injury to determine whether transplanted
microvessels augment axon infiltration. The efficacy of these scaffolds will be determined
primarily by immunohistochemistry to evaluate axon infiltration, inflammation and scar
formation. These experiments will evaluate the effects of cell-seeded peptide injections for
spinal cord repair.
Aim 2: Align injectable, self-assembled peptide hydrogels seeded with
mesenchymal stem cells using magnetic fields following contusion spinal cord injury. The
second aim will validate a post-injection method to magnetically align scaffold fibers to
facilitate axon regeneration in the rostral-caudal direction at the site of spinal cord injury.
Stem cell-seeded scaffolds containing magnetic particles will be delivered at the site of a
rat model of a contusion spinal cord injury in the presence of a magnetic field to align the
fibrous network. Similar to Aim 1, the primary metric to assess the injury response will
involve immunohistochemistry to determine axon alignment. These studies will measure
the paracrine release from the MSC to assess the molecular mechanisms underlying their
response.
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Aim 3: Interrogate axon infiltration into 3D-printed scaffolds with heterogeneous
mechanical properties in a transection spinal cord injury model. This aim will tune scaffold
mechanics to mimic native surrounding spinal cord tissue. The mechanics of uninjured
spinal cord tissue will be described by both atomic force microscopy and rheology to
characterize both microscale and macroscale properties of native tissue. 3D-printed
GelMA scaffolds will be used to replicate the mechanical properties and geometries of the
surrounding spinal cord. Additionally, the effects of cell-seeded scaffolds on functional
benefits will be examined in a rat model of a transection injury. Immunohistochemistry
will be the primary metric to assess axon infiltration and connection following transected
spinal cord injury.
Impact: The proposed studies will combine a novel bioengineering approach with
established cell-based therapies to create a new strategy for axon connectivity in the central
nervous system. Although these experiments focus primarily on SCI, they have direct
relevance for other pathologies involving an inability to restore axonal connectivity. For
example, if successful, this approach can also be applied to traumatic brain injury (TBI)
and other forms of central nervous system injury.
2.7. Innovation
This proposal highlights several innovative aspects for injectable scaffolds:
1) Although there are several studies that have interrogated the efficacy of various
scaffolds on axon infiltration after central nervous system injury, these
approaches have yet to induce neurovascular interactions. These studies will
include microvascular endothelial cells that exhibit a blood-spinal cord barrier
to stimulate axon infiltration and guide neuronal regrowth.
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2) Another innovative aspect is the ability to magnetically align of injectable
scaffolds post-delivery. Magnetic particles provide a means to tune topologies
post-injection in peptide scaffolds by facilitating axon infiltration in a rostralcaudal direction for spinal cord injury repair. These studies will compare the
effects of MSC-seeded scaffolds on the infiltration of axons and the attenuation
of inflammatory response. Reports from ongoing clinical trials have
demonstrated the potential efficacy of autologous MSC transplantation on
functional benefits in human patients of spinal cord injury[59].
Other innovative aspects for solid transplantable hydrogels:
1) Although prior approaches have used 3D-printing to create scaffolds for the
purpose of central nervous system regeneration, previous fabrication methods
preclude the seeding of cells within the bulk of the hydrogels. The method
described here capitalizes on a recently described approach to pattern complex
topologies within cell-permeable scaffolds. Therefore, not only can conduits
with predetermined geometries be delivered with cells, but host cells can also
invade into the bulk of the scaffold and facilitate nutrient and oxygen transport.
An approach combining 3D-printing with cell-permeable hydrogels has not
previously been used for central nervous system regeneration.
2) The fabrication strategy described in this proposal also allows for tuning of the
mechanical properties of the scaffold. The mechanics of the central nervous
system following injury is substantially different than other organs: whereas
fibrotic scarring in other regions of the body decrease the compliance of the
injured tissue, the site of a CNS injury exhibits an increased compliance. Thus,
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the mechanical properties of spinal cords are determined locally by examining
the stiffness of gray and white matter and globally to examine whether ratios of
gray-to-white matter will contribute to the bulk mechanics. These parameters
will be used to alter the mechanical properties of 3D-printing scaffolds to
provide a means to tune mechanics for optimal axon regrowth.
3) The proposed studies will also compare the effects of seeding MSCs with
seeding endothelial cells on the infiltration and outgrowth of axons from the
scaffold. The proposed studies will assess the benefit of delivering MSCs within
a scaffold to improve retention and to provide guidance pathways for infiltrating
axons.
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Chapter III
Materials and Methods
3.1. Experimental Methods for Vascularization of Injectable Peptides
3.1.1. Rheological Testing
To characterize the mechanical properties of the RADA-16I peptide scaffold, 40
µL of 1 mg/mL peptide in 10% sucrose (the concentrations used for in vitro and
transplantation studies) was loaded onto a 1°, 20-mm cone-plate rheometer (TA
Instruments) fitted with a Peltier plate to maintain a temperature of 37 °C. 1% cyclic strain
applied at a frequency of 1-Hz was applied to the gel for 600 s. The rheological properties
of the scaffold were measured every 5 s, and storage modulus and loss angle were used to
evaluate polymerization of the peptide.
3.1.2. Microfluidic Device Fabrication
RADA-16I hydrogels were polymerized inside a polydimethylsiloxane (PDMS)based microfluidic device fabricated using soft lithography [24]. Microfluidic devices were
fabricated using positive-featured PDMS stamps containing a rectangular chamber with
dimensions of 4 mm × 6 mm × 1 mm (L × W × H). A layer of PDMS was used to enclose
the rectangular reservoir and act as a membrane securing the peptide gel. Nine ports were
punctured in this layer with a biopsy punch to provide access to culture medium pipetted
on top of the device. After assembling the two layers, the devices were cooked at 150 °C
and placed on a 22 mm × 22 mm glass cover slip.
3.1.3. Cell Culture
Human cerebral microvascular endothelial cells (HCMEC/D3) were cultured in
gelatin-coated tissue culture plates. Modified endothelial growth medium-2 (mEGM-2)
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was prepared as previously described [25]. The final concentrations of reagents in mEGM2 were 5 µg/mL ascorbic acid (Sigma), 1 ng/mL bFGF (Peprotech), 1% chemically defined
lipid concentrate (Thermo Fisher), 5% fetal bovine serum (FBS) (VWR), 10 mM HEPES
buffer (VWR), 1.4 µM of hydrocortisone (VWR), and 1% penicillin-streptomycin (VWR).
HCMEC/D3 were thawed 5 days prior to seeding and medium was changed every other
day. For in vivo experiments, human brain vascular pericytes (HBVP) were cultured in
tissue culture plates with DMEM (VWR) supplemented with 10% FBS, 1% penicillinstreptomycin, and 1X MEM Amino Acid Solution (VWR).
3.1.4. In-Vitro Cell Seeding
HCMEC/D3 from confluent plates were washed with PBS and suspended in 10%
sucrose at a density of 5 × 106 cells/mL. The solution containing cells was centrifuged and
the cell pellet was resuspended in a 1:1 mixture of 20% sucrose and self-assembling
peptide, yielding the final concentrations of 10% and 1 mg/mL and 5.0 × 106 cells/mL.
Following suspension, the peptide-cell solution was injected into the central chamber of
the microfluidic device and placed in a 6-well cell culture plate. mEGM-2 containing 10%
FBS was carefully added directly above the chamber, and after an hour of incubation, the
media was replaced with mEGM-2 supplemented with 0.1 mg/mL vascular endothelial
growth factor (VEGF) and 1 mg/mL phorbol 12-myristate 13-acetate (PMA) and incubated
for five days to stimulate vascular formation similar to a previous approach [23].
3.1.5. Permeability Testing
In order to assess barrier function within the vascular structures after five days in
culture, 500 µL of 4-kDa dextran was pipetted on the surface of the microfluidic device
containing the cellular peptide gel to test the integrity of tight junctions of endothelial cells.
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Images were taken on a Nikon A1 confocal microscope at intervals of 10 s for 15 min at z
heights corresponding to vessel lumens. The images were then imported to ImageJ for
analysis. The permeability coefficients were quantified using a method in a previous study
[8], [26]. Briefly, assuming the dextran concentration remains constant in the surroundings
and the cylindrical geometry of the vessels, permeability coefficients can be calculated
from the flux of solute across an area of the capillary using Fick's First Law of Diffusion.
Here, assuming a fixed concentration outside the vessels, the dextran concentration was
directly correlated with fluorescent intensity yielding the following equation for
permeability coefficient: 𝑃 =

𝑟

𝑑𝐼

2𝐼𝑜 𝑑𝑡

, where dI/dt is the change of fluorescent intensity

inside the lumen, r is the radius of the vessel, and Io is the maximum intensity through the
duration of the experiment.
3.1.6. Immunocytochemistry
Devices were fixed in 4% paraformaldehyde (Alfa Aesar) at room temperature for
20 min. Afterwards, cellular peptide hydrogels were permeabilized with of 0.2% Triton X100 (Sigma) for 30 min at room temperature. Peptide hydrogels were then removed from
the central chamber of the devices and blocked by 3% bovine serum albumin (BSA) for 30
min at room temperature. These permeabilized hydrogels were incubated with 1:250 antiZO-1 (Cell Signaling) for two nights at 4 °C. These gels were then washed thoroughly in
PBS and incubated with 1:500 DAPI, 1:50 FITC-phalloidin, and 1:500 secondary antibody
Cy-3 at 37 °C for 60 min. Images were acquired on a Nikon A1 laser scanning confocal
microscope.
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3.1.7. Preparing Cells in Injectable Peptide Scaffold
GFP-labeled HCMECs/D3 were mixed with GFP-labeled HBVP, given that these
cells have been shown to support endothelial viability post-transplantation [8]. The cells
were suspended in 20% sucrose at densities of either 2.4 × 106 cells/mL or 5 × 106 cells/mL
with a ratio of 5:1 HCMEC/D3 to HBVP, consistent with the ratio used in previous studies
[8], [27]. The cell solution was combined with self-assembling peptide to yield final
concentrations of 10% sucrose and 1 mg/mL peptide. Freshly made peptide with or without
cells was injected into the lesion area immediately after preparation.
3.1.8. Spinal Cord Surgery and Transplantation
Surgeries were conducted at the Drexel University Queen Lane Medical Campus.
All procedures were approved by the Institutional Animal Care and Use Committee of
Drexel University College of Medicine, and were carried out according to the National
Institutes of Health (NIH) Guide for the Care and Use of Laboratory Animals. Female
Sprague-Dawley rats (225–250 g, n = 12) were used in this specific aim. They were housed
with a 12-h/12-h light/dark cycle. Food and water were available ad libitum.
Rats were anesthetized with 5% isoflurane until unconscious followed by 3% isoflurane
during surgery. A laminectomy was performed at C5, and a contusion lesion was made
with IH impactor (force, 150 kdyne; impactor tip diameter, 2 mm. Precision Systems and
Instrumentation, LLC, Lexington, KY) at the right side of the cord. Muscles and skin were
closed in layers. Buprenex (0.015–0.02 mg/kg, Reckitt Benckiser, Richmond, VA) was
administered subcutaneously post-surgery. One week after contusion, rats were
anesthetized with isoflurane for scaffold transplantation. The lesion area was re-opened,
and 10 µL of peptide was injected into the lesion area as an acellular control (n = 4). 10 µL
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of peptide with cells in two densities were injected into lesion area: 2.4 × 106 and 5.0 ×
106 (n = 4 per group), with a ratio of 5:1 endothelial cells to pericytes for both densities.
Therefore, a total of 12 animals were used for these studies. Muscles were sutured and skin
was closed with clips. Buprenex (0.015–0.02 mg/kg) was administered subcutaneously
post-surgery. All animals received subcutaneous injection of cyclosporine A
(Sandimmune; Novartis Pharmaceuticals, East Hanover, NJ, USA) at a dose of 1 mg/100
g per day beginning 2–3 days before transplantation and continuing until the end of the
experiments. Animals survived for 2 weeks after scaffold transplantation.
Transplantations were performed one week following contusion to model subacute
spinal cord injury, both to maintain translational relevance since patients undergoing
treatment would do so in weeks to years post-injury (subacute to chronic phase), and to
create a stable injury environment that has been used extensively in previous models [28]–
[30].
3.1.9. Tissue Preparation
Two weeks after peptide scaffold transplantation, animals were overdosed with
Euthasol (J. A. Webster) and then transcardially perfused with 100 mL of ice-cold 0.9%
saline and 500 ml of ice-cold 4% paraformaldehyde in phosphate buffer. The spinal cords
with injury/transplant area were removed and placed in 4% paraformaldehyde overnight,
followed by cryoprotection in 30% sucrose/0.1 M phosphate buffer at 4 °C for at least 3
days. Spinal cords were embedded in M1 medium (Thermo Fischer Scientific) and cut in
sagittal sections of 20-µm. Six separate groups of serial sections (approximately 10–15mm in length) were collected onto glass slides coated with gelatin. Therefore, adjacent
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slices on each slide were from levels spaced approximately 120-µm apart within the cord.
Slides were kept at 4 °C.
3.1.10. Immunohistochemical Preparation
Sagittal sections were processed for immunohistochemical staining with primary
antibodies against GFAP (1:1000, Chemicon) for astrocytes, GFP (1:1000, Millipore) for
both GFP labeled HCMECs/D3 and HBVP, Tuj (1:500, Covance) for axon growth, ED-1
(1:500, Serotec) for macrophage, ZO-1 (1;500, Cell signaling) for tight junction, 5-HT
(1:20,000, Immunostar) for serotonergic axons. Sections were washed with phosphate
buffered saline, blocked with 10% goat or donkey serum for 1hr at room temperature, and
then incubated in primary antibodies at room temperature overnight. Species-specific
secondary antibodies (goat anti-mouse, goat anti-rabbit, or donkey anti-goat conjugated to
FITC or rhodamine, 1:1000, Jackson ImmunoResearch) were applied for 2 h at room
temperature and the slides were cover-slipped with fluoromount-G with DAPI
(SouthernBiotech).
3.1.11. Immunohistochemical Analysis
Immunohistological sections (20-µm thickness) were imaged with a Nikon A1 laser
scanning confocal microscope. Using Nikon Elements software, z-stacks of these slides
were generated. For each animal, four adjacent sections on each slide (covering an
approximate height of 480-µm) were chosen at a position based on the approximate
location of GFP-positive cells in the high cell density condition, in order to assure similar
regions of the spinal cord were analyzed across all conditions. Axons inside the scaffolds
were quantified using the multi-point tool in ImageJ. To quantify axon density, the
approximate injury area was measured using the freehand selection tool in ImageJ. Axon
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densities were calculated by dividing the number of axons by the injury area in each
section. Neurovascular interaction was quantified by isolating channels for axons (Tuj) and
vascular (GFP) structures and using fast Fourier transforms (FFT) to convert spatial
coordinates into Fourier frequency data. Gaussian distributions were fit to this frequency
data, and alignment was quantified by comparing distributions generated from axon (Tuj)
and vessel (GFP) Fourier frequencies from five histological sections per cell density. To
determine significance between these distributions, the difference in mean angles were
compared using a paired t-test, with p > 0.05 indicating no significant difference between
the GFP and Tuj signals. Finally, for the measurement of GFAP and ED-1-positive areas,
the freehand selection tool was again used to trace the area of positive staining for each
marker for four adjacent sections per animal. Mean and standard deviations of these area
measurements were then calculated.
3.1.12. Microvessel Quantification
In order to identify the presence of lumens within the peptide scaffold, multicellular
structures identified in the maximum projection of the x-y plane were observed in either
the x-z or y-z planes to identify the presence of a void within the structure. In the in vitro
experiments, the phalloidin stain was used to identify these tubular structures, and the GFP
signal was used in the in vivo data. We then measured the length of the microvessels by
comparing the maximum projection in the x-y plane to 3D volume views to determine the
beginning and end of each microvessel position. This process was completed in both the in
vitro and in vivo analyses.
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3.1.13. Statistics
One-way ANOVA and post-hoc Tukey's HSD tests were used to calculate
statistical significance unless otherwise specified. Statistical significance of the in vitro
data and microvessels’ quantification were calculated using a Welch Two Sample t-test,
assuming normal distributions with unequal variances between groups. Significant
difference was denoted with p-values less than 0.05. In vivo measurements (12 animals
total) were averaged from 4 histological sections per animal.
3.2. Experimental Methods for Magnetic Alignment of RADA-16I
3.2.1. Hydrogel Preparation
For in vitro experiments, peptide hydrogels were constructed by seeding carbonyl
iron microparticles (MP) prior to polymerization. 2-mg/mL RADA-16I was mixed with
20% sucrose containing 0.2-wt% MP in a 1:1 mixture to create final concentrations of 1mg/mL and 0.1-wt% peptide-MP hydrogels. Carbonyl iron magnetic particles (BASF)
were obtained to employ magnetic alignment in injectable peptides [119]. A magnetic field
of approximately 100-gauss (G) was applied to the hydrogel to induce alignment.
Unaligned scaffolds were polymerized in the absence of the field. Scaffold polymerization
was replicated by carefully adding Dulbecco’s Modified Eagle Medium (DMEM/F12)
containing 10% FBS to the hydrogels similar to a previous method [60].
3.2.2. Scanning Electron Microscopy (SEM)
Peptide hydrogels were thoroughly washed and fixed with 5% glutaraldehyde (VWR)
for 2 hours at 4°C. After fixation, RADA-16I scaffolds were rinsed with PBS and
sequentially dehydrated in 10%, 20%, 30%, 40%, 50%, 60%, 70%, 80%, 90% and 100%
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ethanol (VWR) for 5 minutes at room temperature. These samples were lyophilized for 2
hours and sputter coated prior to SEM imaging.
3.2.3. Microfabricated Chamber Fabrication
Unaligned and aligned cell-seeded peptide hydrogels were polymerized inside a
polydimethylsiloxane (PDMS)-based device fabricated using soft lithography [32].
Briefly, a chamber was fabricated using positive-feature PDMS stamps with dimensions of
2 mm × 2 mm × 2 mm (L × W × H). The patterned PDMS was cured at 150°C for 7 mins,
and then a second layer of PDMS was added on top of the patterned layer to create an
enclosed reservoir.
3.2.4. CopGFP Lentiviral Infection
P3 hMSCs cultured in DMEM/F12 were infected with copGFP lentivirus (Santa
Cruz) at a MOI of 1 and in culture medium containing 5 µg/mL polybrene for 24 hours.
These cells were washed and incubated with DMEM/F12 and exposed to 2 µg/mL
puromycin until ~90% of adhered cells expressed green fluorescent protein (GFP).
Transfected cells were cultured and used for in vitro and in vivo experiments.
3.2.5. In-Vitro Alignment and Infiltration
Human mesenchymal stem cells (hMSCs) were cultured in DMEM/F12 containing
10% FBS (VWR) and 1% penicillin-streptomycin (VWR) until confluent. hMSCs were
resuspended in 10% sucrose, 0.1 wt% MPs and 1 mg/mL peptide hydrogels at a density of
7.5 × 106 cells/mL, given previous studies have shown that hMSCs promote functional
recovery [120], [121]. Following resuspension, the cell-MP-peptide solution was injected
into the chamber of the microfabricated device and DMEM/F12 was carefully added to
initiate polymerization. A 100-G field was applied to the gels during polymerization to
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align fibers, with unaligned hydrogels used as a negative control. To interrogate the effects
of hMSCs on promoting axon infiltration, aligned acellular MP-peptide hydrogels were
used as an additional control condition.
In order to simulate axon infiltration, 21 × 106 cells/mL of rat-derived E14 neural
progenitor cells (NPCs) were seeded on the surface of acellular and cell-seeded peptide
scaffolds to interrogate the effects of magnetic alignment on axon alignment. NPCs were
isolates using a previously published protocol [122]. Hydrogels were cultured in
DMEM/F12 supplemented with 20 ng/mL neurotropic factor-3 (NT-3) (PeproTech) to
maintain the viability of NPCs and facilitate their differentiation to neuronal restricted
precursors (NRPs), distinguished by Tuj+ staining.
3.2.6. Immunocytochemistry
Devices were fixed in 4% paraformaldehyde (Alfa Aesar) at room temperature for
20 min. Afterwards, MR-peptide hydrogels were permeabilized with of 0.2% Triton X-100
(Sigma) for 20 min and blocked by 10% normal donkey serum (NDS) (Sigma) for 10 min
at room temperature. These gels were incubated with 1:500 Tuj-1 (BioLegend) and 2%
NDS for 2 hours followed by incubation of 1:500 DAPI, 1:50 Texas-red phalloidin and
1:500 DyLight 650 conjugate. Images were acquired on a Nikon A1 laser scanning
confocal microscope.
3.2.7. Total BDNF Quantikine ELISA
Supernatants were obtained from each condition and total BDNF concentrations
were measured using a quantikine ELISA kit (R&D Systems). BDNF-concentrations were
prepped and quantified using the manufacturer’s protocol. Briefly, supernatants were
added onto each well and thoroughly washed, then secondary antibodies and color reagents
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were added. Absorbances were read at 450 and 540 nm and the corrected absorbances were
taken by the difference between the two wavelengths.
3.2.8. Spinal Cord Surgery and Transplantation
In vivo surgeries were performed at the Drexel University Queen Lane Medical
Campus. The Institutional Animal Care and Use Committee of Drexel University College
of Medicine approved all animal procures and these experiments were proceeded according
to the National Institutes of Health (NIH) Guide for the Care and Use of Laboratory
Animals. Six female Sprague-Dawley rats (225-250 g) were housed with a 12-h/12-h
light/dark cycle in this work. These rats were administered with 5% of isoflurane until
unconscious and the concentration of anesthesia was reduced to 3% during surgery. To
induce contusion spinal cord injuries, a laminectomy was performed at C5 and a force of
150 kdyne (impactor tip diameter: 2 mm, Precision Systems and Instrumentation, LLC)
was applied to the cord. Muscles and skin were sutured and Buprenex (0.015 - 0.02 mg/kg,
Reckitt Benckiser) was subcutaneously administered post-surgery. The rats received
cyclosporine A (Sandimmune; Novartis Pharmaceuticals) subcutaneously at a dose of 1
mg/100 g/day 2-3 days prior to transplantation.
Two weeks after injury, rats were anesthetized with isoflurane and lesion area was
re-opened during scaffold injection. GFP-labeled hMSCs from confluent plates were
washed and suspended in 10% sucrose at a density of 7.5 × 106 cells/mL. The cell solution
was centrifuged and the pellet resuspended in 20% sucrose and 0.2-wt% MP and selfassembling peptide, yielding final concentrations of 10% sucrose, 0.1-wt% MP and 1mg/mL RADA-16I. Prior to injection, permanent magnets were placed under the rat to
direct the magnetic field along the rostral-caudal direction. The peptide solution was mixed
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immediately before injection in both acellular and cell-seeded conditions. 10 µL of peptide
containing 0.1 wt% of MP was injected at a rate of 50 nL/s into the injury site as acellular
controls (n = 2). Additionally, four rats received 10 µL of cell-seeded MP-peptide scaffolds
with a density of 7.5 × 106 cells/mL and divided the animals into two groups: without
magnetic field (unaligned) and magnetic field applied (aligned). Peptide hydrogels
polymerized due to injection into physiological pH. Our previous rheological data indicates
polymerization occurs within 90 seconds [60]. Furthermore, to ensure rostral-caudal
alignment, the magnetic field remained in place until suturing was finished. Thus, 6 total
rats were used for these studies. Muscles and skin were sutured and closed with clips.
Buprenex (0.015 – 0.02 mg/kg) was subcutaneously administered after the surgery and
cyclosporine A treatments were continued daily until the end of the experiments. Animals
were sacrificed 2 weeks after peptide injections.
3.2.9. Tissue Preparation
Two weeks following peptide injections, rats were overdosed with Euthasol (J. A.
Webster) and transcardially perfused with 100 mL of 0.9% saline and 500 mL of 4%
paraformaldehyde in phosphate buffer. Spinal cords were removed and incubated in 4%
paraformaldehyde overnight and cryoprotected with 30% sucrose/0.1 M phosphate buffer
at 4°C for 3 days. The cords were transferred to M1 medium and cryosectioned with
thicknesses of 20 µm. Sagittal sections were separated into six groups (approximately 10
– 15 mm in length) with gelatin coated glass slides. Adjacent sections on glass slides were
approximately 120-µm spaced apart within the cord and the histological slides were kept
at -20°C.
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3.2.10. Immunohistochemical Preparation and Analysis
Histological sections were thoroughly washed and blocked with 10% goat or
donkey serum, for 1 hour prior to immunohistochemical staining. Sections were selected
for immunohistochemical staining using primary antibodies against GFP (1:1000,
Millipore) for hMSC, Tuj (1:500, Covance) for axon growth, GFAP (1:1000, Chemicon)
for astrocytes, ED-1 (1:500, Serotec) for macrophage, 5-HT (1:20,000, Immunostar) for
serotenergic axons, CGRP (1:2000, Peninsula) for peptide and regenerating sensory axons,
and GAP43 (1:1000, Millipore) for regenerating axons. These sections were incubated in
primary antibodies overnight at room temperature followed by incubating in speciesspecific secondary antibodies (goat anti-mouse, donkey anti-goat, or goat anti-rabbit
conjugated to FITC or rhodamine, 1:1000, Jackson ImmunoResearch) for 2 hours at room
temperature.

Sections

were

cover-slipped

with

fluoromount-G

with

DAPI

(SouthernBiotech).
Histological sections (thickness: 20-µm) were imaged using a Nikon A1 laser
scanning confocal microscope and z-stacks were generated using the Nikon Elements
software. To determine the location of the scaffolds, brightfield imaging was used to
identify the MPs and 488 laser was used to locate GFP+ cells within the scaffolds and
ensure similar regions across all conditions. Three adjacent sections on each slide (with an
approximate height of 360- µm) were imaged and analyzed. Tuj+ axons, GAP43+ axons, 5HT fibers and CGRP-fibers inside the scaffolds were quantified using the multi-point tool
in ImageJ. Axon densities were calculated by measuring the injury area using the freehand
selection tool in ImageJ and dividing the number of axons by the injury area of each
histological section. Axon alignment was quantified using the angle tool by drawing a line
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with two points in the DIC channel and the third point in the TRITC channel to create an
angle between the axons and direction of the magnetic field. Finally, inflammatory
responses were calculated by normalizing the intensity of ED-1 within the scaffold to the
maximum intensity of an 8-bit image. Mean and standard deviations of the infiltrated
axons, glial scars and ED-1 intensities were then calculated.
3.2.11. Alignment Quantification
Fiber alignment was quantified using fast-Fourier transforms (FFT) to convert
spatial coordinates to Fourier frequencies and these frequencies were fit into a Gaussian
distribution. Elongation factor (E) was quantified using the previous protocol [123].
Briefly, the longitudinal axis of each axon was divided by the width of the corresponding
axon and subtract by 1.
3.2.12. Statistics
One-way ANOVA and post-hoc Tukey’s HSD tests were performed to calculate
statistical significance unless stated otherwise. Statistical analysis of the fiber alignment
via SEM was calculated using a Welch Two Sample t-test, assuming normal distributions
with unequal variances between groups. Significant differences were denoted with pvalues less than 0.05. In vivo analysis (6 animals total) was averaged from 3 histological
sections per animal.
3.3. Experimental Methods for Dynamically Altering Protein Hydrogels
3.3.1. Hydrogel Preparation
Magnetic-responsive (MR) hydrogels were constructed by seeding carbonyl iron
microparticles (MPs) into hydrogels prior to polymerization. Hydrogels either consisted of
collagen, fibrin, or a mixture of collagen and high molecular weight (2-2.4 MDa)
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hyaluronan. Collagen hydrogels were fabricated using a previous method at concentrations
of either 2 or 5-mg/mL [124], [125]. 1 mg/mL fibrin hydrogels were polymerized using
1U/mL of thrombin. Hyaluronan was added to the collagen gels without any additional
crosslinking. The collagen and collagen/HA concentrations were chosen to match previous
studies of astrocyte-seeded hydrogels [126]. MPs were sterilized with 70% ethanol, dried
by evaporation, and subsequently submerged in distilled water at a stock concentration of
100 wt% (w/v) 24 hours prior to hydrogel preparation.
3.3.2 Scanning Electron Microscopy (SEM)
Carbonyl iron microparticle were seeded into 5 mg/mL collagen hydrogels with a
concentration of 0.1 wt% for matrix characterization. Hydrogels were thoroughly washed
and fixed with 5% glutaraldehyde (VWR) for 30 minutes at 4°C. Following fixation, MRgels were rinsed with PBS and sequentially dehydrated in 20%, 50%, 70%, 90% and 100%
ethanol (VWR) for 10 minutes at room temperature. These samples were lyophilized for 2
hours and sputter coated prior to SEM imaging.
3.3.3. Mechanical Characterization
Rheology measurements of collagen-based hydrogels were conducted on a
magnetorheometer attachment for a TA Discovery rheometer (TA Instruments). MR
collagen hydrogels were deposited directly onto the 37°C surface plate of the rheometer
after mixing. A nonferrous 20-mm Peltier plate was set to a gap height of 300 µm. 1%
cyclic strain at a frequency of 1 Hz was applied to the MR gels for a total time of 900 s,
with no magnetic field applied during the first 300 s. Magnetorheological properties were
measured after hydrogel polymerization for the remaining 600 s. Each magnetic pulse was
axially applied for 20 s, with an initial field strength of 500 Oersted (Oe), followed by 2000
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Oe and then 4000 Oe. The storage and loss moduli were used to evaluate the tunable
mechanical properties of the magnetic-collagen hydrogels. In order to determine whether
the direction of the field altered the rheological results, MR collagen hydrogels were
polymerized on a non-ferrous Peltier plate (gap height: 24-µm) of a DHR-2 rheometer (TA
Instrument) with a 20-mm non-ferrous plate. The cyclic strain and frequency settings
matched experiments using the magnetorheometer. A magnetic field of 500-Oe was
applied in the transverse direction using permanent magnets. The rheology of fibrin- and
PDMS-based materials was measured with an Anton Paar rheometer (MCR502, Anton
Paar GmbH, Germany) equipped with a temperature-controlled electromagnet that
produces a uniform field perpendicular to the face of a disk-shaped samples between
parallel plates. The sample diameter was 20 mm and height varied from 0.3 to 1 mm. Shear
storage and loss moduli (G' and G", respectively) were measured as a function of magnetic
field at 1% shear strain a frequency of 10 rad/s.
In order to visualize MP displacement within fibrin hydrogels, unpolymerized
hydrogels were added to a transparent stage and a 20-mm flat disk applied controlled levels
of shear stress using a Bohlin rheometer. For these experiments, a constant magnetic field
of 1000-Oe was applied horizontally across the disk-shaped hydrogel using permanent
magnets. The instantaneous MP deformation was tracked during the initial application of
shear stress, and then tracked during the creep period while the rheometer tracked creep
angle.
3.3.4. Confocal Microscopy
Confocal microscopy was used to examine whether the application of the magnetic
field caused carbonyl iron MP displacement. For these experiments, 1 wt% of Nile-red
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magnetic MPs were embedded in 2 mg/mL and 5 mg/mL collagen hydrogels. After
suspending the MPs, gels were either immediately transferred to the stage of a Nikon A1
laser scanning confocal microscope or incubated for an hour to polymerize. Images were
taken with a 40X oil immersion objective (Nikon) to visualize displacement over a total
period of 40-s. The gels were unmagnetized for the first 20-s and a magnetic field of 2700Oe was applied to the gel for an addition 20-s for all conditions.
3.3.5. Microfabricated Devices
Cell-seeded collagen hydrogels were polymerized inside a polydimethylsiloxane
(PDMS)-based device fabricated using soft lithography [60], [127]. Briefly, a rectangular
chamber was fabricated using positive-feature PDMS stamps with dimensions of 4 mm ×
6 mm × 2 mm (L × W × H). The feature layers were cured at 150°C for 7 mins. The top of
these devices remained open to allow nutrient and oxygen transport. In addition to nutrient
transport, we found that adding 3-mm glass spacers on each side of these devices
substantially increased cell viability.
3.3.6. Cell Culture
Human coronary artery smooth muscle cells (hCASMC) infected with RFPLifeAct using an MOI were thawed at passage 6 and cultured in smooth muscle cell growth
medium (Lonza) until confluency. P5 normal human astrocytes (NHA) were cultured in
astrocyte growth medium (AGM, Lonza) according to a previous protocol [128].
3.3.7. Live Cell Microscopy of hCASMC-Mediated Bead Displacement
Cells were seeded into MR collagen-hyaluronan composite hydrogels at a cell
density of 1×106 cells/mL. A particle concentration of 0.5 wt% was chosen to visualize
local deformation mediated by hCASMCs. Following suspension, the collagen-cell
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solution was injected into the central chamber of the microfabricated device and placed in
a tissue plastic 35 mm petri dish that contained 5 mL of SMC growth medium. These
hydrogels were incubated for 15 min and transferred to a live-cell incubator (Nikon). For
gels exposed to a magnetic field, four neodymium magnets (two N52 magnets on each side,
1.5” x 0.5” x 0.125”, BX882-N52, K&J Magnetics) were positioned to apply a
horizontally-oriented 500-Oe magnetic field to the hydrogels. Encapsulated cells were
imaged using an inverted epi-fluorescent microscope (Nikon) for 3 hours. These images
were then analyzed using FIJI and MATLAB.
3.3.8. Cell Viability Assays
To examine the effect of MP concentration on astrocyte viability, P5 NHAs were
seeded at a density of 1×106 cells/mL into 5-mg/mL collagen hydrogels with the following
concentrations: 0 wt%, 0.5 wt%, 2.5 wt%, 5 wt%, 10 wt%, and 20 wt%. After 3 days, cellseeded hydrogels were washed twice with PBS and stained with 4 mM of calcein AM and
2 mM of EthD-III (Biotium) for 45 minutes at room temperature. Hydrogels were imaged
on a Nikon A1 laser scanning confocal microscope. Five frames were used for each
condition to quantify cell viability.
3.3.9. Cell Morphology and Mechanotransduction Studies of Normal Human Astrocytes
Similarly, NHAs were seeded into MR collagen hydrogels at a density of 1×106
cells/mL. A magnetic particle concentration of 5 wt% was used to increase the effect of the
magnetic field on substrate stiffness. The collagen-cell solution was injected into the
central chamber of the microfabricated devices, placed in a P100 tissue plastic petri dish,
and incubated for 15 minutes. For gels exposed to a magnetic field, eight neodymium
magnets (four N52 magnets on top and underneath, 1.5” x 0.5” x 0.125”, BX882-N52,
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K&J Magnetics) were positioned with 2-mm spacers to apply a vertically-oriented 7,700Oe magnetic field. A computational model constructed in COMSOL was used to calculate
the magnitude and uniformity of the field in the region of the hydrogels. In order to
construct the model, a gauss meter (Model 410, LakeShore) was used to measure the
surface field of a single BX882-N52 magnet and at locations 2- and 4-mm removed from
the surface. The Br parameter in COMSOL was set at 1.145 to produce the correct surface
field (1,780-Oe). The measurements of the gauss meter at 2- and 4-mm from the surface
showed good agreement with the computational results . The COMSOL model predicted a
field of approximately 7,200-Oe, which was close to the 7,700-Oe field measured by the
gauss meter. For negative controls, the same NHA density was seeded into hydrogels
without magnetic particles and also exposed to a 7,700-Oe magnetic field. All cell-seeded
hydrogels were incubated with AGM throughout the duration of the experiment.
3.3.10. Immunocytochemistry
For immunocytochemical staining, culture medium was aspirated from the gels
followed by PBS wash and fixation in 4% paraformaldehyde (Alfa Aesar) at room
temperature for 30 min. Gels were then permeabilized with 0.2% Triton X-100 (Sigma) for
30 min at room temperature. MR collagen hydrogels were removed from the central
chamber and blocked with 3% bovine serum albumin (BSA) for 30 min at room
temperature. The permeabilized hydrogels were incubated with 1:200 yes-associated
protein (YAP) primary antibodies overnight at 4°C. These gels were then washed
thoroughly with PBS and incubated with 1:250 DAPI, 1:50 TRITC phalloidin, and 1:200
secondary antibody 488 at 37°C for 60 min. Images were acquired on a Nikon A1 laser
scanning confocal microscope.
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3.3.11. Calcium Transient Measurements in hCASMC-Seeded Hydrogels
To examine the effect of rapidly changing matrix mechanics on cell response,
LifeAct-transfected hCASMC were seeded into 2 mg/mL collagen with and without 2.5
wt% MPs at a density of 1 × 106 cells/mL. The cell-seeded hydrogels were incubated at
37°C with smooth muscle cell growth media 24h prior to imaging to preserve optimal
spreading. To observe calcium transients in real time, SMCs were incubated with 20 µM
Fluo-4 AM (Life Technologies) in DMEM/F-12 medium consisting of 10% FBS, 20 mM
HEPES, and 0.25% pluronic acid for 45 minutesMENDELEY CITATION PLACEHOLDER 0. These
hydrogels were then washed with F-12 media containing 10% FBS and 20 mM HEPES for
15 minutes and transferred to a live-cell incubator. Images were taken every 1-s for 9
minutes at a wavelength of 488-nm to visualize instantaneous calcium transients with
respect to dynamically tuning the mechanical stiffness of the hydrogels. An external field
of 2850-Oe was applied to the gels (indicated as “w/ MF”) for 3 minutes, removed for 3
minutes (“w/o MF”), and finally reapplied for the final 3 minutes of the experiment.
Rheology indicated an increase in storage modulus from approximately 100-Pa to 650-Pa
for these conditions. These experiments were conducted with and without magnetic
particles to provide a negative control.
3.3.12. Image Analysis
Spreading of NHAs was quantified using ImageJ. Z-stacks images of
DAPI/phalloidin stained cells were taken with a laser scanning confocal microscope using
a 40X oil immersion objective (Nikon) and condensed to create 2D images. For cell
morphology measurements, the freehand selection tool was used to trace the area of the
cell. Mean and standard deviations of these morphology measurements were then
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calculated. For measurements of cell shape index (CSI) and YAP nuclear localization in
3D, quantification was conducted as previously described [129]. Briefly, binary masks
were generated for 3D image stacks of DAPI and actin images by using Otsu’s intensitybased thresholding method. The counter function was used to calculate cell volumes (V)
and surface areas (A0). The obtained values were used to calculate 3D CSI using the
1

following equation: 𝐶𝑆𝐼 =

2

𝜋 3 (6𝑉)3
𝐴0

[129]. The generated metric defined a line with a CSI

of 0 and a sphere with a CSI of 1. For nuclear YAP localization measurements, single cell
images were analyzed and quantified. Images were converted into binary masks to create
thresholds for each color channel to determine nuclear volume (Vn) and cell cytoskeleton
volume (Vc). The counter function was again used to determine Vn and Vc along with the
intensity of YAP signal within those regions. The measured values were inserted into the
following equation to generate YAP nuclear/cytosolic ratio: 𝑁𝑢𝑐𝑙𝑒𝑎𝑟 𝑌𝐴𝑃 =
𝑁𝑢𝑐𝑙𝑒𝑎𝑟 𝑌𝐴𝑃 𝑠𝑖𝑔𝑛𝑎𝑙
𝑉𝑛
𝐶𝑦𝑡𝑜𝑠𝑜𝑙𝑖𝑐 𝑌𝐴𝑃 𝑠𝑖𝑔𝑛𝑎𝑙
𝑉𝑐

[129]. In order to quantify calcium transients, fluorescent intensities

inside of each cell were measured for individual frames during the three phases of the
hydrogels. Normalized Fluo-4 fluorescence ratios were expressed as (F-F0)/(Fmax-F0)
(instantaneous fluorescence – initial fluorescence/maximum fluorescence - initial
fluorescence) to compare differences in calcium cycling. Transients were averaged for each
condition, and the initial slope of the transient was measured by fitting a line to the increase
in normalized fluorescence.
3.3.13. Statistical Analysis
Two-sample t-tests, one-way ANOVA, two-way ANOVA, and post-hoc Tukey’s
HSD tests were used to calculate statistical significance. Statistical significance of the
38

rheological MP deformation was calculated using a paired t-test, assuming normal
distributions with unequal variances between groups. For morphology and YAP studies,
measurements were averaged from at least 25 cells per condition.
3.4. Experimental Methods for 3D-Printed Scaffolds
3.4.1. Solution Preparation
Dissecting and measuring artificial cerebrospinal fluids were fabricated to maintain
the viability of isolated spinal cords using previous methods[130], [131]. Briefly, dissecting
artificial cerebrospinal fluid (d-aCSF) was supplemented with 191 mM sucrose, 0.75 mM
K-gluconate, 1.25 mM KH2PO4, 26 mM NaHCO3, 4 mM MgSO4, 1 mM CaCl2, 20 mM
glucose, 2 mM kynurenic acid, 1 mM (+)-sodium L-ascorbate, 5 mM ethyl pyruvate, 3 mM
myo-inositol, and 2 mM NaOH. Additionally, measuring artificial cerebrospinal fluid (maCSF) was composed of 121 mM NaCl, 3 mM KCl, 1.25 mM NaH2PO4, 25 mM NaHCO3,
1.1 mM MgCl2, 2.2 mM CaCl2, 15 mM glucose, 1 mM (+)-sodium L-ascorbate, 5 mM
ethyl pyruvate, and 3 mM myo-inositol. The resulting pH of these fluids was ~7.3. All the
above reagents were purchased from VWR.
3.4.2. Spinal Cord Preparation
Bovine spinal cords were isolated directly into quart-sized containers of ice-cold
dissecting artificial cerebrospinal fluid (d-aCSF) at Bringhurst Meats (Berlin, NJ). After
measuring the lengths of the cords, each tissue was divided into three regions: cervical
(between 31 and 35 inches from caudal end), lumbar (between 20 and 26 inches from
caudal), and sacral (10 inches from caudal). All regions were cut along the transverse
anatomical plane, and then immersed in m-aCSF for testing.
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3.4.3. Spinal Cord Mechanical Characterization
All spinal cord mechanics were examined within 1 to 2 hours after extraction and
experiments were done within 7 to 8 hours, as previous studies have shown that cords
preserved in aCSF maintain their mechanical properties over this timespan[130]. The local
mechanics of the gray and white matter were examined using AFM. Spinal cord sections
were fixed to the petri dishes using transglutaminase that has been shown as a tissue
adhesive[132] and fully embedded in m-aCSF during these measurements. AFM
measurements were taken in triplicates in regions of both gray and white matter using a
20-μm diameter silicon spherical tip with a cantilever spring constant of 0.6 N/m.
Rheology was conducted at several levels of compressive strain to characterize the
macroscopic mechanical properties of the cord at different regions. Measurements were
conducted on a rheometer (Kinexus) with a 20-mm parallel attachment. During rheological
measurements, m-aCSF was pipetted around the tissue to prevent the cord from drying out.
The gap was set with respect to the height of each spinal cord section. The bulk mechanical
properties of the cords were evaluated by measuring the shear modulus at a steady
frequency of 1 Hz and 1% strain for 90 seconds. The test was repeated for successive
compression steps of 100 µm.
A Kibron tensiometer was used to measure the relaxation effects of the gray and
white matter of bovine spinal cords. Tissue sections were submerged in m-aCSF during
relaxation measurements. A 500-µm probe was lowered in the gray and white matter to
interrogate the relaxation profiles within each matter region. The relaxation factors were
calculated by measuring the decay in force with time after indentation.
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3.4.4. Synthesis of Polymer and Photoinitiator
The polymers and initiators for the prehydrogel solutions, including gelatin
methacrylate (GelMA) and lithium phenyl-2,4,6-trimethylbenzoylphosphinate (LAP),
were synthesized as previously described [24]. In brief, GelMA was synthesized through
dropwise addition of methacrylic anhydride to 10 wt% gelatin (Sigma, derived from
porcine skin; type A; gel strength 300) in carbonate/bicarbonate buffer for 4 hours at 5055 °C, then precipitated in ethanol. The precipitate was allowed to dry for multiple days
before resuspension at 20 wt% in PBS. GelMA was sterilized with 0.22 µm filters and
stock solutions were aliquoted then stored at -20 °C until use. LAP was prepared by the
reaction of dimethyl phenylphosphinite and 2,3,6-trimethylbenzoyl chloride under argon
overnight at room temperature. Then 4 molar excess lithium bromide dissolved in 2butanone was added to the reaction mixture. The solution was heated to 50 °C for
precipitation (~10–30 min), cooled to room temperature for 4 hours then filtered with 2butanone and diethyl ether. The resulting precipitate was allowed to dry for several days
before storing under nitrogen at 4 °C until use. Stock solutions were prepared at 200 mM
in PBS, sterile filtered, and protected from light until use.
3.4.5. Preparation of 3D-Printed Scaffolds
For all fabrication of hydrogel scaffolds, prehydrogel mixtures were prepared
containing 15 wt% GelMA, 17 mM LAP, 2.255 mM tartrazine photoabsorber, and 10%
glycerol in sterile 1x PBS. The Volumetric-α Bioprinter used in fabrication was previously
developed by the Jordan Miller lab and Volumetric [24]. This stereolithography-based 3D
printer used a polydimethylsiloxane (PDMS) coated Petri dish as a vat for the prehydrogel
mixture and a build platform with a bonded frosted-glass slide onto which the cured gel
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would attach during printing. After transferring the prehydrogel solution into the vat, the
build platform was then lowered to the first fabrication layer position to start printing. A
custom Matlab script was used to create the 2D photomasks from a 3D model. Grayscale
patterning was the method used for outputting a hydrogel with the desired mechanical
heterogeneity of localized regions within this specific aim. The grayscale patterning uses
light intensity values between 0-100%, representing black to white, to change the extent of
polymerization of the hydrogel. This process included an analysis of the 3-dimensional
model, separating them into even 50-µm sections in the z-direction, then applying the
grayscaled pattern on top of the resulting slices to create the final photomasks. A built-in
software on the printer was used to import the photomask and control the apparatus by
sending GCode commands for vertical movement of the build platform and images to the
projector. The photomasks are projected in sequence for a set exposure time of 14.5
seconds and light intensity of 20 mW/cm2 (at 100% grayscale) for each projection to build
the 3D hydrogel object through layer-by-layer photopolymerization. After printing was
complete, the 3D fabricated hydrogels were removed from the glass slide of the build
platform with a razor and equilibrated in multiple sterile PBS washes. The 3D models of
L4 rat lumbar regions of the spinal cord were created in Blender. The grayscale light
intensity value for the simulated white matter was 75% and the gray matter was 100%. The
hydrogels were printed in groupings of 8.
3.4.6. Scanning Electron Microscopy (SEM)
The microstructure of 3D-printed GelMA hydrogels was examined using a
scanning electron microscope (FEI SEM). The scaffolds were frozen with liquid nitrogen
and lyophilized for 2 hours. The freeze-dried samples were cut in cross-section and sputter
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coated for 30 seconds per sample. The porosity was analyzed by measuring pore diameters
with the measure function in ImageJ.
3.4.7. Scaffold Mechanics Characterization
Raster scans (100 µm x 100 µm) were performed to generate force-distance curves
on regions within the regions of gray matter, white matter, and regions that contain both
the gray and white matter. The scaffolds were submerged in PBS during the AFM
experiments. Measurements were employed using a 20-µm silicon spherical tip with a
spring constant of 0.6 N/m. For compression experiments, elastic moduli of 3D-printed
scaffolds were performed using a Shimadzu mechanical tester with a 15-mm parallel plate
and a 1 kilo-Newton (kN) sensor. A strain rate of 10%/s was used to apply compression to
the 3D-printed constructs.
3.4.8. Spinal Cord Surgery and Transplantation
Animal surgeries were conducted at the Drexel University Queen Lane Medical
Campus. All animal procedures were approved by the Institutional Animal Care and Use
Committee of Drexel University College of Medicine and these experiments were
performed according to the National Institutes of Health (NIH) Guide for the Care and Use
of Laboratory Animals. Six female Sprague-Dawley rats (225-250 g) were housed with a
12-h/12-h light/dark cycle in this specific aim. These rats were administered with 5% of
isoflurane until unconscious and the concentration of anesthesia was reduced to 3% during
surgery. To inflict transection spinal cord injuries, a laminectomy was performed at the
thoracic 10 (T10) and aspiration was performed to remove the tenth level of the thoracic.
Upon transplantation, two scaffold conditions were employed: 1) homogeneous hydrogels
that exhibit the same mechanics within the gray and white matter and 2) heterogeneous
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scaffolds that mimic the differences in gray and white matter. Muscles and skin were
sutured and closed with clips. Buprenex (0.015 – 0.02 mg/kg) was subcutaneously
administered after the surgery. Animals were sacrificed 2 weeks after peptide injections.
3.4.9. Bovine Spinal Cord Immunohistochemistry
Bovine spinal cord sections were fixed with 4% paraformaldehyde on ice for 40
minutes, sectioned at 20 µm thick, and mounted onto gelatin-coated slide. The slides were
washed with phosphate buffered saline (PBS) and sections were blocked with 1% bovine
serum albumin (BSA) for 30 minutes at room temperature. Anti-myelin primary antibodies
(VWR) were diluted at a ratio of 1:200 in dilution buffer consisted of 1% BSA (VWR),
0.3% Triton X-100 (Sigma), and 0.01 sodium azide (VWR) and incubated overnight at 2
to 8 °C. The slides were washed thoroughly with PBS and secondary antibodies were
incubated at room temperature for 60 minutes at a ratio of 1:500. DAPI stains were added
to each slide for an addition incubation time of 5 minutes at room temperature. Finally,
sections were washed and mounted in anti-fade mounting media.
3.4.10. Rat Spinal Cord Immunohistology
Two weeks following transplantations, rats were overdosed with Euthasol (J. A.
Webster) and transcardially perfused with 100 mL of 0.9% saline and 500 mL of 4%
paraformaldehyde in phosphate buffer. Spinal cords were removed and incubated in 4%
paraformaldehyde overnight and cryoprotected with 30% sucrose/0.1 M phosphate buffer
at 4°C for 3 days. The cords were transferred to M1 medium and cryosectioned with
thicknesses of 20 μm. Sagittal sections were separated into six groups (approximately 10 –
15 mm in length) with gelatin coated glass slides. Adjacent sections on glass slides were
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approximately 120-μm spaced apart within the cord and the histological slides were kept
at -20 °C.
Histological sections were thoroughly washed and blocked with 10% goat or
donkey serum, for 1 hour prior to immunohistochemical staining. Sections were selected
for immunohistochemical staining using primary antibodies Tuj (1:500, Covance) for axon
growth, GFAP (1:1000, Chemicon) for astrocytes, and CGRP (1:2000, Peninsula) for
sensory axons. These sections were incubated in primary antibodies overnight at room
temperature followed by incubating in species-specific secondary antibodies (goat antimouse, donkey anti-goat, or goat antirabbit conjugated to FITC or rhodamine, 1:1000,
Jackson ImmunoResearch) for 2 hours at room temperature. Sections were cover-slipped
with fluoromount-G with DAPI (SouthernBiotech).
3.4.11. Immunohistochemical Analysis
Immunohistological sections (thickness: 20 µm) were imaged on a Nikon A1 laser
scanning confocal microscope to generate z-stacks (approximately 10 slices with a 2-µm
step size) in the Nikon Elements software. For DAPI quantification, the number of cell
nuclei was normalized to the area of each scan (1 mm2) and the 488 laser was used to
identify the presence of myelin within bovine spinal cord sections. Myelin quantification
was performed by normalizing the intensity of myelin stains within 1 mm2 measured areas.
For transplantation analysis, three adjacent sections on each slide (approximately 360 µm
in height) were scanned and analyzed. Tuj+ axons and CGRP fibers inside the scaffolds
were quantified using the multi-point tool in ImageJ. Infiltration distance was analyzed
using the measure tool in ImageJ to determine the lengths of which axons infiltrate.
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3.4.12. Statistics
One-way ANOVA and post-hoc Tukey’s HSD tests were performed to calculate
statistical significance unless stated otherwise. Statistical analysis of mechanical
heterogeneity was calculated using a Welch Two Sample t-test, assuming normal
distributions with unequal variances between groups between the gray and white matter of
the scaffolds. Significant differences were denoted with p-values less than 0.05. In vivo
analysis (6 animals total) was averaged from 3 histological sections per animal.
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Chapter IV
Results
4.1. Vascularization of Self-Assembled Peptide Scaffolds for Spinal Cord Injury
Repair
4.1.1. RADA-16I Polymerization Within a Microfabricated Well
Initial experiments were conducted to verify that the RADA-16I hydrogel could
support the formation of BSCB-integrity microvessels in vitro within a microfluidic device.
Previous studies have demonstrated the ability of RADA-16I to support the growth of
microvasculature [47], but vessels exhibiting tight junctions have yet to be fabricated
within these scaffolds. First, a microfabricated reservoir created an enclosed, threedimensional environment for vascularization and featured ports for nutrient and ion
exchange with the surrounding culture medium. Fig. 1A shows a schematic of the device
indicating the location of the nine ports within the 4 mm × 6 mm × 1 mm rectangular
reservoir that encloses RADA-16I hydrogel seeded with cerebral-derived endothelial cells.
Fig. 1B provides a photograph of the device, with red food dye (Allura Red AC) added to
the sucrose used in the scaffold formulation to indicate the position of the peptide within
the device.
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Figure 1. 3D vascularization in vitro. Microfluidic device (A) schematic and (B)
photograph. (C) Storage modulus and loss angle of RADA-16I during scaffold
polymerization. (D) Scanning electron micrograph showing hydrogel microstructure
(scale bar = 3-µm).

Rheology was then used to characterize the mechanical properties of the selfassembling peptide outside the device, and to study the viscoelastic properties during
polymerization of the scaffolds. Ten minutes after exposing the peptide to culture medium,
the RADA-16I hydrogel reached an equilibrium storage modulus of 31 Pa and loss angle
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of 3° (Fig. 1C). These results suggest that RADA-16I is primarily elastic and has a lower
storage modulus than both healthy CNS tissue and glial scars that form after CNS injury
[31,32]. Scanning electron microscopy (SEM) (Fig. 1D) was used to characterize the
microstructure of RADA-16I within the microfluidic device, demonstrating the formation
of 59.8 ± 12.7 nm-diameter fibrils and 111 ± 32.0 nm pore sizes, which is consistent with
previous analyses of RADA-16I peptide scaffolds [47].
4.1.2. Fabrication of Blood-Spinal Cord Barrier (BSCB) Integrity Microvessels In-Vitro
Having characterized the peptide hydrogel, experiments were conducted to verify
that the device could support the formation of BSCB-integrity microvessels within the
peptide scaffold. Endothelial cells were seeded into the scaffold and cultured in endothelial
medium containing VEGF and PMA, two factors known to induce vascular formation in
3D scaffolds [133]. After five days of incubation in static conditions, actin staining
revealed the presence of clearly defined lumens (diameter: 22 ± 6.2 µm, length: 195 ± 70.
µm, n = 6) within the multicellular structures, indicating the formation of microvessels
within the scaffold (Fig. 2A). In order to determine whether the endothelial cells
maintained their tight-junction forming phenotype, the microvessels were stained for
zonula occludins-1 (ZO-1), a scaffolding protein that localizes to cell-cell junctions in the
BSCB. Confocal microscopy revealed that the microvessels within the RADA-16I
hydrogel stained positive for ZO-1 at cell-cell junctions.
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Figure 2. Microvessel formation within RADA-16I peptide scaffolds after 5 days.
(A,B) Confocal microscopy stacks (i) and their cross-sections (ii) showing lumens (white
arrows) labeled with FITC-phalloidin (green), ZO-1 (red), and DAPI (blue). Scale = 50µm (Cross-section scale = 15-µm). (C) 4-kDa FITC-dextran permeability test for control
conditions at time 0 and 15 min (i). (D) Permeability test with thrombin at time 0 and
15 min (i). White dashed lines display microvessels. Scale = 20-µm (E) Schematic of
permeability measurements. (F) Permeability quantification, data presented as mean
± s.d. *p < 0.05, (n = 4).

To further validate the barrier function of these microvessels, permeability testing
with 4-kDa dextran was performed to measure transport across the microvessels.
Resonance scanning confocal microscopy facilitated high-scan rates (1.5 s per scan) that
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measured the diffusion of the dextran into the microvessel lumens at 10-second intervals
for a period of 15 min. During that period, a minimal amount of dextran diffused into the
lumens of untreated microvessels (Fig. 2C). 10 U/mL of thrombin was added to the
surrounding culture medium to disrupt the integrity of the barrier and to serve as a positive
control for dextran transport across the microvessel wall, given its ability to disrupt
endothelial tight junctions. In the presence of thrombin, dextran was able to diffuse into
the microvessel lumens at a faster rate, as shown in Figure 2D. By measuring the rate at
which the fluorescence intensity changed within the microvessels, a permeability
coefficient was calculated for both the control and thrombin test conditions. The
permeability coefficients displayed in Figure 2E indicated that thrombin significantly
increased the permeability of the barrier, and that the control permeability agreed with
previous results for tight-junction-containing microvessels [32]. The permeability
experiments also provided insight into microvessel interconnectivity: there were separate
regions of dextran exclusion, indicating multiple and distinct microvessel structures within
the scaffold at the five-day time point. Overall, these findings demonstrate the ability of
the RADA-16I hydrogel to support the formation of microvessels with BSCB-integrity in
an in vitro setting.
4.1.3. Characterization of Microvessel Formation in RADA-16I Post-Transplantation
After demonstrating the formation of microvessels in vitro, a preliminary in vivo
experiment was designed to examine whether microvessels would also form in RADA-16I
hydrogels after injection into a rat spinal cord injury model. One week after a contusion
injury at the cervical level, three scaffold conditions were injected into the site of injury:
acellular, low cell density (2.4 × 106/mL), and high cell density (5.0 × 106/mL). GFP-
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labeled endothelial cells were combined with GFP-labeled pericytes, due to previous
studies that have shown pericytes to support microvessel viability post-transplantation
[32]. Cell density was varied to determine whether the delivery of more cells would
produce an increased vascular density, given previous results indicating that higher
densities of astrocytes in collagen-hyaluronan hydrogels induced hypoxia within the
scaffold [125]. Furthermore, the two conditions also yielded insight into whether the
response to the transplant was dependent upon the density of cells delivered to the injury.
Immunohistochemistry examined the morphology of microvessels and their
interactions with host axons at two weeks post-transplantation. Confocal imaging indicated
the presence of clearly defined lumens similar to those observed in vitro in both conditions
(Fig. 3A-B). The diameters of these lumens were measured to be 9.0 ± 3.1 µm (n = 31) for
the low cell density condition and 7.4 ± 2.4 µm (n = 26) in the high cell density condition.
The microvessel length was also quantified and found to be 99 ± 60. µm (n = 31) in the low
cell density condition and 100 ± 46 µm (n = 26) in the high cell density condition. Twosample t-tests indicated no significant difference in the number, diameter, and length of the
lumens between the two cell density conditions. These measurements are consistent with
previous studies that quantified capillary diameters in the blood-brain barrier [134], [135],
in microvessels within previously described in vitro scaffolds [32], and in the rat spinal
cord, where the smallest vessel diameter was found to be 7.4 µm [136]. Positive ZO-1
staining (shown in the low cell density condition in Fig. 3C) suggested that the
microvessels maintained their tight junction phenotype after two weeks following
transplantation. The ZO-1 appeared more punctate in vivo compared to the in vitro
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microvessels described in Figure 2. This difference could be due to vessel maturity;
microvessels were evaluated after day 5 in vitro and after two weeks in vivo.
In addition to characterizing the microvessel structure, neurovascular interaction
between the GFP-positive microvessels and Tuj-positive host axons was also quantified.
For both cell densities, the microvessels were in close proximity to the surrounding host
axons which grew into the scaffold transplant (Fig. 3Aii and Bii, white arrows). To quantify
neurovascular interaction, fast Fourier transforms (FFT) were calculated for microvessels
and host axons in both cellular conditions to convert spatial coordinates into Fourier
frequency data, and Gaussian distributions were fit to this data. Fig. 3D,E shows similar
distributions between the two signals for both low and high cell density conditions, which
suggests alignment between GFP-positive microvessels and Tuj-positive axons in the site
of injury. Paired t-tests were calculated from the difference of means of these Gaussian
distributions, and the resulting p-values of 0.39 and 0.72 for low and high cell conditions
respectively indicate insignificant differences between the distributions and therefore
alignment between the microvessels and axons (Fig. 3F). This result is consistent with
previous results regarding neurovascular interaction in the aftermath of SCI.
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Figure 3. Microvascular structures form in the peptide scaffold following transplantation
and facilitate neurovascular interaction. Lumen formation in (A) low cell density and (B)
high cell density, (Ai) and (Bi) x-y plane, (Aii) and (Bii) y-z plane, providing an
orthogonal view to visualize lumens. DAPI (blue), GFP (green), Tuj (red). (C)
Examination of tight junctions in low cell density condition. DAPI (blue), GFP (green),
ZO-1 (red). Scale = 20-µm (8-µm for cross-sections). FFT pixels showing alignment of
microvessels and axon interaction in (D) low cell density and (E) high cell density. (F) pvalues comparing the FFT distributions of GFP-microvessels and axons in both
conditions using paired t-tests from the means of the Gaussian distributions (n = 5 per
condition).
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4.1.4. Cellular Peptide Hydrogels Augment Host Axon infiltration in Spinal Cord Injury
Model
Having shown that the scaffold supported microvessel formation in vivo, we
interrogated whether the presence of microvessels within the peptide increased the density
of Tuj-positive axons at the site of the contusion injury. Due to the nature of contusion
injury, we could not distinguish between spared axons and axons infiltrating into the
scaffold. Therefore, serial histological sections were imaged in a confocal microscope and
stacked to create a volume rendering of the injury site. Supplemental videos 1 (low cell
density) and 2 (high cell density) provide 3D renderings of four individual 20-µm sections
separated by approximately 120 µm. Representative sections from these stacks are
provided in Fig. 4A. As the images show, the scaffolds seeded with microvascular cells
resulted in significantly higher axon density in the injury site in both cell-seeded conditions
compared to acellular controls (Fig. 4B,C). 5-HT was also probed in these samples to
evaluate the potential presence of descending, motor specific tracts. Although there was no
significant difference between total axon density, quantification of 5-HT-positive axons
indicated that scaffolds seeded with the low cell density resulted in significantly more
serotonergic-specific axons at the site of injury compared to both acellular and high cell
density conditions (Fig. 4D,E), though the high cell density condition still had a
significantly higher number of 5-HT-positive axons than the acellular control.
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Figure 4. Regeneration of spinal and serotonergic axons in the injury area. General axons
stained with Tuj grew into (Ai) acellular scaffold, (Aii) low cell density scaffold, and
(Aiii) high cell density scaffold. DAPI (blue), GFP (green), and Tuj (red). (B) General
axon quantification. Data presented as mean ± s.d. *p < 0.05. (C) Axon density
quantification. Data presented as mean ± s.d. *p < 0.05 and **p < 0.001. Serotonergic
axon (5HT) grew into (Di) acellular scaffold, (Dii) low cell density scaffold, and (Diii)
high cell density scaffold. DAPI (blue), HCMEC/D3 and HBVP GFP (green), and 5HT
(red). (E) Serotonergic axon quantification values. Data presented as mean ± s.d. *p <
0.05 and **p < 0.001. Scale = 100-µm.

However, staining for GAP43 (Fig. 5) indicated that the high cell density resulted
in a significant increase in the presence of regenerating axons within the injury area
compared to both the acellular and low cell density condition, though the low cell density
condition still had significantly higher GAP43-positive axons compared to the acellular
condition. Therefore, whereas low cell density results in significantly higher 5-HT-positive
axons, the high cell density results in significantly higher GAP43-positive axons. Overall,
these results demonstrate that vascularizing RADA-16I can effectively increase axon
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growth and density following SCI, and that characteristics of this response are dependent
upon the concentration of microvascular cells injected with the peptide.

Figure 5. Microvascular structure formation guides axons regrowth. Regenerating axons
stained with GAP43 proliferated into (Ai) acellular, (Aii) low cellular density, and (Aiii)
high cellular density conditions. DAPI (blue), GFP (green), and GAP43 (magenta). (B)
Quantification of GAP43 axons within injury area. Data presented as mean ± s.d. *p <
0.05 & **p < 0.001. (Ci-iii) provides isolated channel for GAP43. Scale = 100-μm.
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4.1.5. Evaluation of Injury Area and Inflammation Following Transplantation
After demonstrating that the presence of microvessels significantly increased the
density of both general and serotonergic axons at the injury site, we interrogated the effect
of the vascularized peptide on inflammation and scar formation in this region. Antibodies
for glial fibrillary acidic protein (GFAP) and ED-1 were used to assess the presence of
activated astrocytes and macrophage/microglia, respectively. Figure 6A indicated that the
GFAP-positive area was significantly reduced in animals receiving cell-seeded peptide
injections, though there was no significant difference between the two cell densities (Fig.
6B). This result demonstrates that the vascularized scaffolds reduced the size of the injury
area, given previous studies that have quantified injury area based on GFAP staining [122],
[137]. This finding is also consistent with previous studies showing that cell-seeded
scaffolds reduce the injury area [138].
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Figure 6. Quantification of injury area and inflammation following injection of peptide
hydrogels. Reactive gliosis in response to peptide hydrogels in (Ai) acellular peptide,
(Aii) low cell density, and (Aiii) high cell density. DAPI (blue), GFP (green), GFAP
(magenta). (B) Injury area quantification. Data presented as mean ± s.d. *p < 0.05, **p <
0.001 (C) Inflammatory response following scaffold transplantation, (Ci) acellular
peptide, (Cii) low cell density, and (Ciii) high cell density. (D) Inflammation area
quantification. Data presented as mean ± s.d. *p < 0.05, **p < 0.001. Scale = 100-µm.

A similar response was found when staining for ED-1. In the acellular condition,
ED-1-positive staining was present throughout the injury site. However, the ED-1 staining
was localized to the location of the peptide injection in both the low and high cell density
conditions (Fig. 6C). Quantification of the positive-ED-1 area indicated a significant
reduction in both cell-seeded conditions compared to the acellular controls. Higher
magnification images of the GFAP and ED-1 staining are provided in Figure 7. Thus, these
results again show that the presence of the microvascular structures within the peptide has
a beneficial effect on the healing response.
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Figure 7. High magnification images of GFAP. (A,Bi) Control (acellular), (A,Bii) low
cellular density, and (A,Biii) high cellular density scaffolds. DAPI (blue), GFP (green),
and GFAP (A) or ED-1 (B) (magenta). Scale = 35-μm.
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4.2. Magnetic Alignment of Injectable Hydrogel Scaffolds for Spinal Cord Injury
Repair
4.2.1. Fiber Alignment Within a Microfabricated Device
In vitro experiments were first performed to validate the approach of aligning
fibrous networks by applying magnetic fields to hydrogels containing carbonyl iron
magnetic microparticles (MPs). Given our previous work using interstitial flow to align
microvessels in collagen hydrogels [32], experiments were conducted to determine
whether a similar degree of alignment could be achieved by applying magnetic fields to
MP-seeded peptide gels. In order to determine the minimum threshold of carbonyl iron
particles to facilitate fiber orientations, RADA-16I hydrogels polymerized within a 2 mm
× 2 mm × 2 mm (L × W × H) microfabricated chamber were seeded with various particle
concentrations: 0.01 wt%, 0.05 wt%, and 0.10 wt%. A 100-G magnetic field was applied
to the hydrogels to induce fiber alignment during the polymerization process. Brightfield
images demonstrated alignment of MPs under the presence of a 100-G field (Fig. 8A-C)
compared to hydrogels polymerized in the absence of a field (Fig. 8D).
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Figure 8. 3D alignment in vitro. (A–E) Brightfield images various concentrations of
MPs in peptide hydrogels. Scale = 50 μm. (F–J) SEM images of fibers. Scale = 5 μm.
(K–O) Fast-Fourier transform quantification of fiber orientations. (P) Average widths
of the FFT distributions. Data presented as mean ± s.d. *P < 0.05.

Furthermore, aligned scaffolds were also seeded with human mesenchymal stem
cells at a density of 7.5 × 106 cells/mL to interrogate whether initial cell seeding mitigated
magnetic-induced fiber alignment (Fig. 8E). To assess fiber alignment, scanning electron
microscopy (SEM) was used to determine fiber orientations with respect to the magnetic
field. Although the magnetic field was applied to peptide hydrogels containing 0.01 wt%
and 0.05 wt% of MPs (Fig. 8F,G), SEM indicated that fibers were arranged in random
orientations. However, Figure 8H demonstrated that the orientation of fibers aligned with
the applied magnetic field at a concentration of 0.10 wt% of MPs, indicating a minimum
particle threshold needed to align peptide networks. Moreover, peptide hydrogels were
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seeded with 0.1 wt% of MPs in the absence of a magnetic field to provide an unaligned
control. Figure 8I shows random alignment of fibers without the magnetic field applied.
Additionally, cell-seeded scaffolds verified that magnetic-induced fiber alignment was not
affected by initial cellular integration (Fig. 8J). In order to quantify the alignment observed
by electron microscopy, fast-Fourier transforms (FFT) were calculated from the images.
FFT pixels revealed that fibers in the 0.1 wt% MP-aligned condition appeared to have
smaller distributions compared to the other conditions (Fig. 8K-O). To quantify these
Gaussian curves, the widths of these distributions at their half-heights were averaged across
both conditions. Figure 1P shows that the averaged width of fibers exposed to an external
magnetic field at 0.1 wt% exhibits a significantly higher correlation to aligned particles.
These results are consistent with previous studies regarding magnetically aligned collagen
fibers [17].
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4.2.2. Facilitated-Orientation of Axon Infiltration In-Vitro
Having demonstrated the ability to align peptide scaffolds using a magnetic field,
initial in vitro experiments were conducted to interrogate whether fiber anisotropy altered
morphology and migration of neural cell types. In these studies, hMSCs were embedded
within the hydrogel due to their established neurotrophic effects [120], [121]. A magnetic
field of 100-G was applied to both acellular and cell-seeded MP-peptide hydrogels to align
the peptide hydrogels. Furthermore, live/dead and BrdU assays validated whether carbonyl
iron magnetic particles affected hMSC viability and proliferation in peptide hydrogels with
and without the particles. Quantification of viability and proliferation markers indicated no
significant difference between MP-seeded and non-MP scaffolds (Fig. 9).
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Figure 9. Viability assays in (A) control hydrogels and (B) 0.1 wt% of MPs. Green =
calcein AM, Red = ethidium homodimer. Scale = 100 µm. (C) Quantification of
live/dead assay. BrdU assays in (D) control (E) and 0.1 wt% MP-seeded hydrogels. Blue
= DAPI, red = BrdU. Scale = 25 µm. (F) BrdU+ cells quantification. Data presented as
mean ± s.d.

After 4 days of incubation, Tuj stains were used to identify the neuronal phenotype
and validate the sufficient timeframe for axon alignment (Fig. 10A). Figure 10Ai shows
NPCs attached to the surface of the hydrogels with minimal axon infiltration into the
scaffolds in the acellular condition. In contrast, Figure 10Aii-Aiii reveal substantially more
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Tuj+ fibers within hMSC-seeded MP-peptide hydrogels, which is consistent with previous
studies given that cell-seeded hydrogels augment axon infiltration following spinal cord
injury [60]. Quantification of axon orientation verified that the presence of a magnetic field
during polymerization significantly increased alignment along the direction of the
magnetic field compared to unaligned controls (Fig. 10B). Figure 10C demonstrates that
the elongation factor, E, of Tuj+ fibers was also significantly longer in the aligned hMSCseeded peptides compared to the unaligned hMSC-seeded condition, which is consistent
with previous observations of topographical cues for neuronal differentiation [139].
ELISAs were conducted to interrogate BDNF in various hydrogel conditions: MP-seeded,
MP + hMSC-seeded, aligned MP NPC-seeded, unaligned MP hMSC+NPC-seeded, and
aligned MP hMSC+NPC-seeded. Quantification revealed that the aligned scaffolds seeded
with hMSCs and NPCs exhibit a significant increase in BDNF concentrations compared to
unaligned scaffolds containing both cell types (Fig. 10D). These results are consistent with
previous results given that aligned scaffolds improved neurite growth compared to
unaligned controls [49], [50]. Overall, these results demonstrate the efficacy of magnetic
alignment to direct axon regrowth and differentiation for spinal cord regeneration.
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Figure 10. Magnetic alignment of Tuj+ fibers in vitro. Axon infiltration in (Ai)
aligned acellular (Aii) unaligned hMSC-seeded and (Aiii) aligned hMSCseeded peptide hydrogels (white dotted line indicates the approximate edge of
the hydrogel). DAPI = blue, GFP = green, Tuj = red. Polar graphs showing axon
alignment in (Bi) aligned acellular, (Bii) unaligned hMSC-seeded and (Biii)
aligned hMSC-seeded peptide scaffolds after day 4. (C) Elongation factor of
infiltrated axons. (D) Total BDNF quantification with respect to each condition.
Data presented as mean ± s.d. *P < 0.05. Scale = 50 μm.
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4.2.3. Interrogation of Magnetically-Aligned Axons Post-Injection
The in vitro experiments verified that 0.1 wt% of MPs were sufficient for scaffold
alignment in response to a 100-G magnetic field. These parameters were then extended to
a proof-of-concept in vivo experiment using an animal model of spinal cord injury. A
contusion injury model was used to increase the clinical relevance of these studies. Two
weeks following a cervical contusion, several conditions were examined for scaffold
injection: (i) acellular with a magnetic field applied, (ii) hMSCs in the absence of a
magnetic field, and (iii) hMSCs with a magnetic field applied. A 100-G magnetic field
oriented in the rostral-caudal direction was applied by placing permanent magnets spaced
16-mm apart underneath the rat during all injections (Fig. 11A,B). Furthermore, a
computational model constructed in COMSOL was used to calculate the magnitude of the
field applied to the cord at approximately 20-mm from the center of the magnets (Fig. 11C).
Animals were sacrificed and the orientation of infiltrated axons was examined by
immunohistochemistry two weeks post-injection. Both confocal and brightfield
microscopy were used to identify the location of transplanted GFP-positive cells and MPs.
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Figure 11. Schematic of post-injection alignment. (A) Photograph of real-time scaffold
injection at the cervical 4-5 following contusive spinal cord injury. (B) Schematic of
alignment set-up during injection. (C) Computational model of the magnetic field
applied to the cord. X indicates the location of the cord with respect to the position of
the magnets. (D) Magnetic field strength along the Xdirection. The orange dot reveals
the magnetic field strength at approximately 20-mm away from the center of the
magnets.
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Figure 12A provides low-magnification images of positively-labeled Tuj fibers
infiltrating the injection site. Figures 12Bi,Biii focus on segments within the scaffolds
highlighting the axons aligned along the rostral-caudal direction while Figure 12Bii shows
random orientations of infiltrated axons. Figure 12C shows that MPs are retained following
the two-week survival. Alignment quantification showed Tuj+ fibers in scaffolds exposed
to an external magnetic field exhibited orientations along the rostral-caudal direction,
consistent with the direction of the field applied during the injection (Fig. 12Di,Dii). In
contrast, axons in the unaligned scaffolds displayed random orientations in the absence of
the magnetic field (Fig. 12Dii). ANOVA tests with post-hoc Tukey tests revealed
statistically significant difference in Tuj+ fiber orientations between all conditions.
Quantification of infiltrated axons demonstrated that scaffolds seeded with hMSC resulted
in significantly higher axon infiltration in the injury site compared to the acellular controls
(Fig. 12E). Therefore, although application of the magnetic field resulted in significantly
higher alignment in acellular and cell-seeded conditions, the presence of cells significantly
increased the number of infiltrating axons.
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Figure 12. Facilitation of Tuj+ axon alignment following MP-peptide injections
post spinal cord injury. Fluorescent images showing axon infiltration in (Ai)
aligned acellular, (Aii) unaligned hMSC-seeded and (Aiii) aligned hMSC-seeded
scaffolds. White arrows represent the direction of the magnetic field during
surgery. Scale = 100 μm. (Bi–Biii) Higher magnification images from A. Scale =
50 μm. DAPI (blue), GFP (green), Tuj (red). (Ci–Ciii) Brightfield images
displaying magnetic particles in each condition. (D) Quantification of Tuj + axon
fibers in each scaffold condition. (E) Quantification of axon infiltration with
respect to each injected condition. Data presented as mean ± s.d. *P < 0.05.
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4.2.4. Evaluation of Sensory and Serotonergic Axons Following Transplantation
In addition to evaluating axon infiltration post-injection, we also evaluated the
presence of ascending sensory-specific and descending motor-specific tracts within the
injected peptide hydrogel. Calcitonin gene-related peptide (CGRP), a peptide widely
expressed in sensory neurons [140], and 5-HT, a monoamine neurotransmitter that is
essential for modulating locomotion [141], were probed to determine the regeneration of
both

sensory

and

serotonergic

axons.

Figure

13A,B

show

representative

immunofluorescent images of CGRP and 5-HT axons in all three conditions.
Quantification of sensory axons demonstrated that cell-seeded scaffolds significantly
augmented the CGRP regeneration compared to acellular controls (Fig. 13C). Though the
length of CGRP axons were significantly longer in the unaligned hMSC-seeded compared
to the aligned hMSC-seeded hydrogels, both cell-seeded scaffolds resulted in significantly
longer CGRP length in the injury area compared to acellular controls (Fig. 13D).
Interestingly, quantification of 5-HT positive axons indicated no significant difference
amongst all conditions (Fig. 13E), suggesting that the incorporation of magnetic particles
did not hinder these axons from regenerating into the scaffolds, and additionally that the
presence of hMSC did not improve recruitment of these fibers.
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Figure 13. Regeneration of sensory and serotonergic axons at the injury site. (A)
Sensory axons stained with CGRP grew into (Ai) aligned acellular, (Aii) unaligned
hMSC-seeded and (Aiii) aligned hMSC-seeded hydrogels. DAPI (blue), GFP (green),
CGRP (magenta). White arrows represent the direction of the magnetic field during
surgery. (B) Serotonergic axons infiltrated into (Bi) aligned acellular, (Bii) unaligned
hMSC-seeded and (Biii) aligned hMSC-seeded scaffolds. (C) CGRP axon quantification
within the scaffolds. (D) CGRP length quantification. (E) Serotonergic axon
quantification values. Data presented as mean ± s.d. *P < 0.05. Scale = 50 μm.
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Since we could not distinguish between infiltrated axons and spared axons in the
contusion injury, growth associated protein 43 (GAP43), a marker for axonal regeneration
[142], was used to access the growth of axons within the scaffolds (Fig. 14).
Immunofluorescence and quantification revealed a significant increase of GAP43 axons;
GAP43 density was augmented within the cell-seeded scaffolds compared to acellular
controls. Overall, these results validate that the magnetic particles did not inhibit the growth
of sensory and motor tracts, and that axon regeneration was stimulated in the hMSC-seeded
scaffolds.
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Figure 14. Assessment of regenerated axons post-injection 2 weeks after spinal cord
injury. (A) Representative images of GAP43 within (Ai) aligned acellular, (Aii)
unaligned hMSC-seeded and (Aiii) aligned hMSC-seeded hydrogels. DAPI (blue), GFP
(green), GAP43 (red). (B) Brightfield images of each condition. (C) GAP43 axon
quantification. (D) Axon density quantification. Data presented as mean ± s.d. *P < 0.05.
Scale = 50-μm.
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4.2.5. Effects of MP-Seeded Peptide Hydrogels on Inflammation and Astrogliosis PostSurgery
Having demonstrated that magnetically aligned cell-seeded scaffolds facilitated
host-axon infiltration and alignment, we interrogated whether the presence of MPs
exacerbated inflammation and scarring. ED-1, a marker for microglia/macrophage was
probed to access the inflammation in response to the injected scaffolds. ED-1 fluorescence
intensities were used to track the immune profile within each experimental group, given
that previous studies have quantified ED-1 by normalizing pixel intensity within the injury
lesion. The histological section indicated the presence of microglia/microphage throughout
the injury site (Fig. 15A). However, ED-1 intensities were significantly reduced in animals
receiving cell-seeded scaffolds (Fig. 15C). This result revealed that hMSC-seeded
scaffolds reduce inflammation, consistent with previous results that cell-seeded injectable
hydrogels attenuate inflammation [60]. Moreover, glial fibrillary acidic protein (GFAP), a
marker for activated astrocytes was used to examine the glial scar formation at the site of
injection. As Figure 15B displayed, GFAP area was consistent throughout all experimental
groups, given previous studies quantified astrogliosis based on GFAP staining [122], [137].
Quantification of GFAP revealed no statistical differences amongst all conditions (Fig.
15D), indicating that hMSC-seeded magnetic injectables did not induce an increase in glial
scar formation. Taken together, these results demonstrate that hMSC-seeded aligned
peptide scaffolds have beneficial effects on inflammation and do not contribute to reactive
gliosis.
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Figure 15. Quantification of inflammation and astrogliosis following injection.
(A) Microglia stained with ED-1 within (Ai) aligned acellular, (Aii) unaligned
hMSC-seeded and (Aiii) aligned hMSC-seeded hydrogels. (B) Reactive gliosis
in response to peptide containing MP scaffolds in (Bi) aligned acellular, (Bii)
unaligned hMSC-seeded and (Biii) aligned hMSC-seeded scaffolds. DAPI
(blue), GFP (green), ED-1 (red), and GFAP (magenta). (C) Intensity of ED-1
within the scaffolds. (D) Injury area quantification. Data presented as mean ±
s.d. *P < 0.05. (A) Scale = 50 μm. (B) Scale = 500 μm.
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4.3. Dynamic Tuning of Protein Hydrogel Mechanics with Carbonyl Iron
Microparticles Guides Three-Dimensional Cell Mechanotransduction
4.3.1. Magnetorheology of Collagen and Fibrin Hydrogels Seeded with Magnetic
Particles
Initial experiments were used to quantify the effect of magnetic fields on the
viscoelastic properties of collagen and fibrin hydrogels seeded with carbonyl iron MPs.
Magnetic fields of increasing strengths were transiently applied to the hydrogels following
polymerization within a cone-plate rheometer fitted with a coil to apply an axial magnetic
field to the hydrogel (Fig. 16A). To demonstrate the dynamic nature of this effect, 5 mg/mL
collagen hydrogels were seeded with different concentrations of magnetic particles
exposed to three increasing magnitudes of magnetic field for a duration of 20 seconds, with
approximately 2 minutes in between application of the fields of 500-Oe, 2,000-Oe, and
4,000-Oe (Fig. 16B). The storage and loss moduli are plotted as a function of time in Figure
16C-D. The largest increase in storage and loss modulus was observed in collagen
hydrogels containing 10 wt% MPs and exposed to a 4,000-Oe magnetic field (Figures
16Ci,Di). The increase in storage modulus appeared to be proportional to the strength of
the field for the range of conditions tested. Moreover, for all conditions, removing the
magnetic field reversed the increase in viscoelastic properties, which is consistent with
previous results [79]. Decreasing the concentration of magnetic particles reduced the
effects of the magnetic field, although the increase remained proportional to the field
strength.
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Figure 16. Magnetorheological characterization of common hydrogels and model
validation. (A) Magnetorheology test setup with axial application of the magnetic field
to hydrogels within a cone and plate geometry. (B) Variation of the magnetic field
controlled by the magnetorheometer. Collagen hydrogel storage moduli with (Ci) 10,
(Cii) 5, and (Ciii) 0.5 wt % MPs. Loss moduli of (Di) 10, (Dii) 5, and (Diii) 0.5 wt %
MPs. Data presented as mean ± s.d. (n = 3). (E) Dependence of 1 mg/mL fibrin storage
modulus on magnetic field strength. (F) Measurement of the PDMS storage modulus,
embedded with 10 wt % MPs, as a function of the magnetic field (blue circles) and
prediction of the analytical model (line).

Next, the magnetic field was applied in the transverse direction to determine
whether the direction of the field could alter the rheological measurements. Similar to the
rheological tests on a magnetorheometer, a magnetic field of 500-Oe was transiently
applied to 5-mg/mL collagen hydrogels seeded with 5 wt% and 10 wt% of MPs for a period
of 20 seconds. The data demonstrated that the storage and loss modulus resulted in similar
magnitudes as the measurements in the magnetrorheometer, which applied a field in the
axial direction (Fig. 17). Increasing the magnitude of the magnetic field also resulted in an
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increase in the storage modulus of a 1 mg/mL fibrin hydrogel, as shown in Figure 16E,
demonstrating the broad applicability of this approach. Overall, these results verify that
previous observations of magnetoviscoelasticity in MR-composite gels [143], [144] can be
extended to protein-based hydrogels containing MPs.

Figure 17. Rheology data for 5 mg/mL collagen embedded with 5 wt% of MPs with a
field of 500-Oe in the transverse direction. (A) Storage modulus and (B) loss modulus.
Data presented as mean ± std (n = 3).
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4.3.2. Analytical Model of Magnetic-Induced Changes to Hydrogel Mechanics
An analytical model was used to provide a mechanistic basis to the rheological
measurements, and MPs were seeded within a polydimethylsiloxane (PDMS) elastomer to
validate the model. PDMS was chosen to test the theoretical model because, unlike
collagen or fibrin, it is a nearly ideal linear, incompressible elastomer with a constant
Poisson’s ratio, affine deformation, and a very small mesh size that ensures no rotation or
slippage of MPs when the field is applied or the sample is sheared. In the presence of a
magnetic field, shear deformation of the gel causes the ferromagnetic MPs in the elastomer
to become misaligned with the imposed field causing volume-distributed torques. The
magnetic permeability of the gel becomes a function of the deformation tensor [145], 𝑢𝑖𝑘 .
In Einstein summation notation:
𝜇𝑖𝑘 = 𝜇 0 𝛿𝑖𝑘 + 𝑎1 𝑢𝑖𝑘 + 𝑎2 𝑢𝑙𝑙 𝛿𝑖𝑘

(1)

where 𝜇 0 is the relative permeability of the undeformed gel, 𝛿𝑖𝑘 is the Kronecker delta, and
𝑎1 and 𝑎2 are constants. Since the hydrogels are incompressible, 𝑢𝑙𝑙 = 0, and the last term
can be omitted. The magnetic anti-symmetric stress, as in magnetic liquids, is
1

𝜎𝑖𝑘 = 2 𝜖𝑖𝑘𝑙 [𝑴 × 𝑯𝟎 ]𝑙

(2)

where 𝜖𝑖𝑘𝑙 is the Levi-Civita symbol, 𝑀 is the magnetization, and 𝐻0 is the external
magnetic field. Taking the z-direction to be the axial direction of the rheometer plate, the
shear stress is then
1

𝜎𝑥𝑧 = 2 𝑀𝑥 𝐻𝑧

(3)

The deformation tensor for oscillatory rheometry can be modeled assuming linear shear
1 𝜕𝑢𝑥

𝑢𝑥𝑧 = 2

𝜕𝑧

The x-component of magnetization can be written as follows:
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(4)

𝜇𝑥𝑧

𝑀𝑥 =

4𝜋

𝐻𝑧

(5)

where 𝜇𝑥𝑧 is the xz component of the magnetic permeability, and 𝐻𝑧 is the z component
of the internal magnetic field within the hydrogel taking the demagnetization into
consideration. Writing 𝜇𝑥𝑧 in terms of equation (1), and accounting for linear strain in (4)
yields:
1 𝜕𝑢𝑥

𝜇𝑥𝑧 = 𝑎1 𝑢𝑥𝑧 = 𝑎1 (2

𝜕𝑧

)

(6)

𝐻

In the case of an incompressible gel, 𝐻𝑧 = 𝜇00 , so the shear stress can be written as:
1

𝐻

2 𝜕𝑢

𝜎𝑥𝑧 = 16𝜋 𝑎1 (𝜇00 )

𝑥

(7)

𝜕𝑧

using the value of 𝑎1 from a previous experiment[146] and noting 𝜎𝑥𝑧 = 𝐺 ′

𝜕𝑢𝑥
𝜕𝑧

, the shear

modulus as a quadratic function of the external field is as follows:
𝐺′ =

1 (𝜇 0 −1)2
40𝜋

𝜇0

𝐻02

(8)

From eq. 8, a plot of G’ vs H was predicted to be quadratic in H, and the quantity µ0 could
be calculated from the fitting parameter. Experimentally, G’ should have a finite value in
the absence of a field due to the elastic properties of the elastomer in which the
ferromagnetic particles are embedded. This value was treated as a constant in the fitting of
the data. This theory was tested with 10 wt% MPs distributed homogenously in PDMS. As
shown in Figure 1F, the increase in shear modulus was well fit by eq. 8, where 𝑎 =
1 (𝜇 0 −1)2
40𝜋

𝜇0

= 6.88 x 10-3. From this parameter, the magnetic permeability µ0 = 2.5 was in

0
reasonable agreement with the value obtained from magnetometry measurements, 𝜇𝑒𝑥𝑝
=

1.1. Although the increasing rates were similar during the application of the magnetic field,
the relative stiffening effect of the fibrin and collagen gels was much greater than in PDMS.
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Moreover, the increases in G’ of fibrin and collagen were closer to linear than to quadratic
in H. The reason for discrepancy with the theory is unknown but could be due to larger
mesh sizes in these hydrogels compared to PDMS, the highly non-affine deformation of
these networks in shear, or the non-linear elastic response of these fiber networks.
Nevertheless, this model provides a mechanistic basis of the observed rheological results,
and implies that the change in stiffness results from the intrinsic properties of the iron
particles and not from an internal stress that they apply to the network in which they are
embedded.
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4.3.3. The Effect of Magnetic Fields on Magnetic Particle Displacement Within
Hydrogels
A key assumption of the analytical model is that the magnetic particles are
constrained within the network. In order to evaluate this assumption, fluorescently-labeled
MPs were seeded within collagen hydrogels and observed by a resonance laser scanning
confocal microscopy. Labeled MPs were tracked over a period of 20 seconds during the
application of a magnetic field in collagen hydrogels of two different concentrations (2 and
5 mg/mL). In contrast to the rheology conducted in Figure 16, the magnetic field was
applied perpendicular to the z-axis using permanent, neodymium magnets (the direction of
the field is shown in Figure 18) to allow higher resolution detection of small displacements.
In order to assess the effect of fiber formation within the hydrogels, the MPs were tracked
before and after polymerization. As Figure 18A-B indicates, a 2,500 Oe magnetic field
caused measurable displacement of the MPs only before polymerization of the 2 mg/mL
collagen gel. Once the hydrogel solidified, the magnetic field did not induce any
measurable displacement of the particles. Figure 18C-D demonstrates a similar effect in
the higher concentration collagen gel. Again, the magnetic field did not cause any
measurable displacement in the polymerized hydrogel. The distribution of MP
displacement over the 20-second period is graphed in Figure 18E-F for the 2 and 5-mg/mL
hydrogels. Figure 18G shows that the collagen concentration had no significant effect on
the total displacement of the MPs prior to polymerization. These findings indicate that the
application of a magnetic field did not cause substantial displacement of the MPs in the
polymerized collagen hydrogels even at the lowest concentration of collagen, indicating
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that the change in viscoelastic properties observed during magnetorheology was not caused
by prestress on the fibrous network.

Figure 18. Displacement of magnetic particles within 2 mg/mL and 5 mg/mL collagen
hydrogels. Confocal images of 0.5 wt% magnetic particles in 2 mg/mL collagen
hydrogels (A) prior to polymerization and (B) post polymerization (20-seconds between
images) (n = 115). Fluorescent images of 0.5 wt% magnetic particles in 5 mg/mL
collagen hydrogels (C) prior to polymerization and (D) post polymerization, (n = 115).
Cyan = without magnetic field, magenta = with magnetic field of 2,500-Oe. Scale = 50µm. (E,F) Quantification of MP displacement in response to a magnetic field in 2 mg/mL
and 5 mg/mL collagen hydrogels. (G) Box plots of MP displacement. *p < 0.05.
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4.3.4. Tracking Magnetic Particle Displacement Within Hydrogels Under Shear Stress
In order to determine the effect of magnetic fields on the displacement of MPs in
the presence of externally applied stress, a constant shear stress was applied by a flat plate
rheometer fitted with a fluorescence microscope [147], so that MP displacement could be
tracked during the initial application of stress and subsequent creep in the hydrogel (Fig.
19A-B). These measurements were conducted at regions located at the same radial distance
from the rotational axis for consistency. In order to demonstrate the broad applicability of
this effect, these experiments used 1-mg/mL fibrin hydrogels containing 1 wt%
fluorescently-labeled MPs. Figures 19C-E indicate the distribution of MP displacement
with and without the presence of a 1,000-Oe field immediately following the application
of 10, 25, and 50-Pa. These findings are consistent with previous studies that found a
distribution of local strain within a fibrous network exposed to global strain [148]. For each
magnitude of stress, the instantaneous MP displacement was substantially reduced in the
presence of a magnetic field. The disparity was most apparent at the lowest level of applied
stress (10 Pa). Not only did the magnetic field reduce the instantaneous displacement, but
it also reduced the spread of the distribution, attenuating non-affine motion. To quantify
this effect, the widths of the distributions at their half-heights were averaged across the
three levels of stress and compared between magnetic and non-magnetic conditions (Figure
19F). The magnetic field also affected the creep behavior of the fibrin hydrogels. The creep
rate was measured with two metrics: the deformation rate of the MPs as well as the creep
angle recorded by the rheometer. Figure 19G shows that the magnetic field significantly
decreased the deformation rate of the MPs at a stress of 50 Pa. These results are consistent
with the creep rate measured by the rheometer plate for stress levels of 25 and 50 Pa plotted
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in Figure 19H. Overall, these results indicate that the magnetic field restricted the
displacement of the MPs within hydrogels exposed to the external mechanical stimulus of
shear stress, suggesting that the presence of the field reduces relative motion between MPs.
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Figure 19. Schematic of the rheometer setup of magnetically responsive fibrin hydrogels
(A) without and (B) with a magnetic field (MF). Quantification of instantaneous MP
displacement undergoing (C) 10, (D) 25, and (E) 50 Pa shear stresses with and without
a 1000 Oe magnetic field (n = 35 per condition). (F) Average width of the instantaneous
displacement distribution. (G) Creep rate measured by tracking MP displacement in
fibrin gels exposed to 50 Pa shear stress over 30 s (n = 3). (H) Creep angle measured
from the rheometer. These fibrin hydrogels contained 1 wt % MPs. *p < 0.05.
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4.3.5. Cell-Mediated Magnetic Particle Displacement
Although rheological experiments revealed the effect of magnetic fields on MP
displacement within a globally deformed fibrous network, this approach could not
elucidate the effect of magnetic fields on local deformation of MPs entrapped within the
fibers. Therefore, live cell experiments were conducted by seeding 1×106 cells/mL human
coronary artery smooth muscle cells (hCASMCs) into 5 mg/mL collagen and 1 mg/mL
hyaluronan composite hydrogels containing 0.5 wt% MPs. The concentration of MP was
chosen to visualize particle displacement in brightfield microscopy. A schematic of the
microfabricated device containing the hydrogel is shown in Figure 20A. Additionally, a
scanning electron microscopy image of the hydrogel containing 0.1 wt% MPs is shown in
Figure 20B.

Figure 20. Physical properties of collagen-MP hydrogels. (A) Schematic of
microfabricated chamber. (B) SEM image of collagen fibers containing MPs. Scale =
100 µm.
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Figure 21A provides a schematic of the cell-seeded hydrogels polymerized within
a microfabricated device, and Figure 21B shows how the magnetic field was applied to the
hydrogel while on the stage of an epifluorescence microscope using neodymium magnets.
The magnets were positioned to apply a uniform field of 500 Oe to the cell-seeded
hydrogels. This combination of magnetic field strength and MP density was chosen to
increase hydrogel storage modulus without affecting the contractility of the smooth muscle
cells: rheological results indicated that the application of a 500-Oe field to collagen
hydrogels seeded with 0.5 wt% MPs increased the storage modulus by a modest amount
(from 500 Pa to approximately 650 Pa).
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Figure 21. Schematic of 3D hydrogels used for live cell microscopy (A) without and
(B) with a 500 Oe magnetic field (MF). RFP-LifeACT-labeled hCASMC in 5 mg/mL
collagen, 1 mg/mL HA, and 0.5 wt % MPs (C) without a magnetic field and (D)
corresponding heat map of MP displacement. (E) Cells and (F) heat map with a magnetic
field. Quantification of MP displacement due to cell motility with (G) 0 (w/o MF) and
500 Oe (w/ MF) (n = 75 MPs per condition). Box-and-whisker plots of (H) MP
displacement. Scale = 25-μm. *p < 0.05.
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We found no significant difference between cell morphology and alpha-smooth
muscle cell actin expression in the hCASMCs between this range of storage moduli (Fig.
22), suggesting similar levels of cell contractility in both conditions. Figure 21C shows a
representative cell at 6-hrs post gel polymerization in the absence of a magnetic field. The
displacement of the MPs in that time was quantified and displayed in the form of a heat
map in Figure 21D. Both the cell and the displacement of adjacent MPs in the presence of
a 500-Oe magnetic field are presented in Figure 21E. As the heat map indicates, the
displacement of the MPs was substantially reduced in the presence of the magnetic field
(Fig. 21F). Quantification of total MP displacement distributions verified that application
of the magnetic field reduced MP displacement (Fig. 21G). Box plots provided in Figure
3H indicate a significant difference in MP displacement. These results are consistent with
the rheological findings: the MPs are constrained from moving relative to one another in
the presence of a magnetic field. Since the MPs are effectively trapped within the fibrous
network, the magnetic field then increases the storage modulus of the hydrogel. This
increase in stiffness was apparent in both global deformation (Figure 19) and local, cellmediated matrix deformation (Figure 21).
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Figure 22. Live-cell morphological studies. Representative images of RFP-LifeACTlabeled HCASMC (A) with and (B) without magnetic field. Quantification of (C) cell
area and (D) cell shape index. Scale bar = 25 µm.

93

4.3.6. Alteration of ECM Mechanics Instantaneously Affects Calcium Transients
In order to highlight the ability of MR hydrogels to instantaneously change 3D
substrate mechanics to an extent that alters the cell response, calcium transients were
measured in smooth muscle cells seeded inside collagen hydrogels with and without MPs.
1 × 106 HCASMC/mL were seeded into 2-mg/mL collagen hydrogels without magnetic
particles as negative controls. The same cell density was seeded into 2 mg/mL collagen
hydrogels containing 2.5 wt% of MPs to observe the dynamic effects of calcium transients.
Application of a magnetic flux of 2850-Oe increased the storage modulus from
approximately 100-Pa to 650-Pa (Fig. 23), yielding a substantial increase in the stiffness
of the hydrogel and providing an opportunity to interrogate how this change in stiffness
altered calcium signaling.
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Figure 23. Rheology data for 2 mg/mL collagen embedded with 2.5 wt% of MPs at
5,000-Oe. (A) Storage modulus and (B) loss modulus. Data presented as mean ± std (n
= 3).

Spontaneous calcium transients were observed to occur at a frequency of
approximately one cycle per three minutes in both MR and non-MP-seeded collagen
hydrogels, so the magnetic field was applied for three minutes (increased storage modulus),
removed for the next three minutes (decrease storage modulus), and subsequently reapplied
for three minutes (re-increase storage modulus).This “on-off-on” provided a means to
directly evaluate how the increase in stiffness affected calcium signaling in the hCASMC
(Fig. 24A). Figure 24B provides an image of Fluo-4-labeled hCASMC in hydrogels
without any magnetic particles as a negative control, whereas Figure 24C shows an image
of hCASMC in MP-seeded collagen hydrogels. Averaged calcium transients indicate no
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significant difference in cells when the field is applied compared to no magnetic field (Fig.
24D). Quantification of the rate of calcium influx also indicated no significant effect caused
by the magnetic field in the absence of MPs as a function of time (Fig. 24E) and averaged
over all measured transients with and without the field (Fig. 24F). The magnetic field also
did not appear to alter the frequency of spontaneous calcium transients in the cells
embedded in the non-MP-seeded collagen gels. Figure 24G shows that the application of a
magnetic field significantly altered the dynamics of calcium transients of hCASMC in MRhydrogels. The period of the transient was significantly shorter and the rate of initial influx
was significantly higher. Quantification of the slope of the transient indicated that the
SMCs increased their rate of calcium influx in response to the higher storage modulus
yielded by the application of a magnetic field, but there was no difference between the
slope of the transient between the first and last three minutes (Fig. 24H). Two-sample ttests between the “on” and “off” condition revealed a significant difference in the slope of
the transient in MR hydrogels (Fig. 24I). These measurements can be compared to previous
studies using smooth muscle cells [149] and cardiomyocytes on 2D substrates with tunable
stiffness[150] and myofibroblasts in collagen gels of differing concentrations [151], though
these experiments were performed under conditions where the time scale for the response
to dynamic changes to stiffness could not be measured. In contrast, the results in Figure 4
are measured after dynamically and reversibly altering stiffness on a second time scale
without any alteration to the pore size of the collagen fibrous matrix. Taken together, these
findings provide new insight into the effect of ECM stiffness on calcium handling in cells
in 3D, and pave the way for future mechanotransduction experiments to interrogate the
mechanisms by which cells respond to dynamically altered ECM mechanics.
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Figure 24. Effects of dynamically altered hydrogel mechanics on cellular calcium
transients. (A) Schematic of the “on–off–on” regimen for both non-MP-seeded and MP
collagen hydrogels. Fluorescence image of Fluo-4 as Ca2+ reporter in (B) 2 mg/mL
collagen and (C) 2 mg/mL collagen and 2.5 wt % MP hydrogels. (D) Average calcium
transients in non-MP-seeded collagen hydrogels with field on (w/ MF) and off (w/o
MF). (E) Slope of calcium transients and (F) initial slope of calcium transients in nonMP-seeded collagen hydrogels. (G) Average calcium transients in MP-seeded hydrogels
with field on (w/ MF) and off (w/o MF). (H) Slope of calcium transients and (I) initial
slope of calcium transients in MP-seeded collagen hydrogels. Scale = 100 μm. *P <
0.01. (n = 5 cells per condition, 10 transients for MF on and 5 transients for MF off per
condition).
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4.3.7. Cell Morphology in Response to Hydrogel Stiffness in 3D
Having demonstrated the short-term, immediate cell response to changing substrate
mechanics, experiments were then conducted to assess long-term changes in cell behavior.
For these experiments, normal human astrocytes (NHA) were used to demonstrate the
flexibility of the approach. Cells were seeded at a density of 1×106 cells/mL into 5 mg/mL
collagen hydrogels containing 5 wt% of MPs. Rheological testing indicated that a magnetic
field of 7,700 Oe increased the hydrogel stiffness from 0.8 kPa to 8.5 kPa (Fig. 25), which
represented a sufficient increase to describe the changes in cell morphology.

Figure 25. Rheology data for 5 mg/mL collagen embedded with 5 wt% of MPs at 7,700Oe. (A) Storage modulus and (B) loss modulus. Data presented as mean ± std (n = 3).
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Furthermore, 5 wt% MPs was chosen due to the high viability of cells seeded in
hydrogels containing that concentration of MPs (Fig. 26). Three conditions were tested: a
magnetic field applied to the cell-seeded hydrogel in the absence of MPs (Fig. 27A), cellseeded hydrogels containing MPs in the absence of a magnetic field (Fig. 27B), and cellseeded hydrogels containing MPs and exposed to the 7,700-Oe magnetic field (Fig. 27C).
Cell morphology was measured at 11 and 22 hours by fixing the cells and staining with
DAPI and phalloidin.

Figure 26. Examination of cell viability in 5 mg/mL collagen with various MP
concentrations. Representative images of Live/Dead stains in (A) 0 wt%, (B) 0.5 wt%,
(C) 2.5 wt%, (D) 5 wt%, (E) 10 wt%, and (F) 20 wt%. (G) Quantification of cell
viability. Scale = 250-µm.
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At 11 hours, the spread area of the cells in hydrogels containing the MPs and
exposed to the magnetic field was significantly reduced, and the cell shape index was
significantly increased compared to the other conditions (Fig. 27D,E). Moreover, the cells
in MP-seeded hydrogels exposed to the magnetic field continued to exhibit reduced spread
area and increased cell shape index (Fig. 27F-I). These findings are consistent with
previous studies in 3D hydrogels showing that one phase, non-degradable hydrogels with
high stiffness reduce cell spreading due to the inability of cells to elastically
deform/mechanically remodel the ECM in 3D [129], [152]. Although the mechanical
properties of these synthetic hydrogels have exhibited a capacity to study
mechanotransduction, the photo-active dynamics affect the hydrogel’s pore sizes. Previous
studies have shown that the stiffening effect in photocrosslinkable hydrogels resulted in a
decrease of dextran diffusivity [153], limiting the ability to dynamically tune substrate
stiffness without altering porosity. The cells in the hydrogels seeded with MPs and exposed
to a magnetic field sense a substantially increased substrate stiffness, even though the
hydrogel composition and pore size is unaffected by the presence of MPs and magnetic
field.
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Figure 27. Schematic of cell experiments with (A) 5 mg/mL collagen in the presence of
a 7,700 Oe magnetic field, (B) 5 mg/mL collagen and 5 wt % magnetic particles (MPs)
without a magnetic field, and (C) 5 mg/mL collagen and 5 wt % magnetic particles
(MPs) with a 7,700 Oe field. Representative images of cells (D) for the three conditions
at 11 h. Representative images of cells (E) for the three conditions at 22 h. Quantification
of (F) cell area and (G) cell shape index (CSI) for the 11 h time point and (H) cell area
and (I) cell shape index (CSI) for the 22 hour time point. DAPI (blue) and F-actin (red).
Scale = 50 μm. *P < 0.05. (n = 15 per condition).
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4.3.8. Dynamic Tuning of Hydrogel Mechanics to Control Cell Mechanotransduction
Altering hydrogel mechanics with magnetic fields yields a useful tool to study cell
mechanics in 3D environments, but the reversibility of the effect substantially amplifies its
impact. These studies interrogated whether tuning hydrogel mechanics with transient
application of a magnetic field (Fig. 28A-B) could control mechanosensing by the
astrocytes. Three different conditions in MP-seeded hydrogels were evaluated: (i) NHA
were allowed to spread in the absence of a magnetic field for a full 22-hr period, (“offoff”), (ii) NHA experienced 11-hrs in the absence of a field and then a magnetic field was
applied for the remaining 11-hrs (“off-on”), and (iii) a magnetic field was applied for the
first 11-hrs and then removed for the remaining time (“on-off”). Figures 28A-C provide
schematics summarizing these conditions. At the end of the 22-hr period, all hydrogels
were fixed and stained with DAPI, phalloidin, and an anti-YAP antibody, given previous
findings that substrate mechanics affects translocation of the transcription factor to the
nucleus [66]. As Figure 28D shows, astrocytes in the “off-off” condition spread and YAP
was diffuse throughout the cytoplasm. In contrast, in Figure 28E, the astrocytes in the “offon” condition exhibited increased YAP staining within the cell nucleus, especially when
compared to cells exposed to the “on-off” condition (Fig. 28F). The was no significant
difference in both the spread area and cell shape index between the “off-on” and “on-off”
conditions, though both were significantly different from the “off-off” control (Fig.
28G,H). Quantification of the YAP staining verified that the “off-on” condition exhibited
significantly increased nuclear translocation in Figure 28I. These results suggest that cells
in the “off-on” condition initially sense a more compliant ECM and begin to spread, but
once the magnetic field is applied the cells sense a stiffer environment and YAP
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translocation increases. In contrast, cells in the “on-off” condition are initially constrained
from spreading by the increased stiffness, but once the magnetic field is removed the cells
sense a softer environment and begin to spread and reduce YAP translocation. These results
mirror the findings in other approaches to dynamically tune substrate stiffness with more
complex alterations to hydrogel properties [72], [129], [150], [154]. Yet, this approach
requires no alteration to hydrogel composition or chemistry to dynamically tune hydrogel
mechanics and interrogate cell mechanotransduction.
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Figure 28. Dynamically tunable hydrogels by transient application of a 7,700 Oe
magnetic field to 5 mg/mL collagen. (A–C) Schematics of “off–off”, “off–on”, and “on–
off” regimens. Representative images of cell morphology in (D) “off–off”, (E) “on–off”,
and (F) “off–on” conditions. Immunofluorescence images showing YAP in (Di) “off–
off”, (Ei) “on–off”, and (Fi) “off–on” conditions. Quantification of (G) cell area, (H)
cell shape index, and (I) nuclear to cytoplasmic YAP ratio. DAPI (blue), F-actin (red),
and YAP (green). Scale = 25 μm. *P < 0.05. (n > 25 cells per condition).
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4.4. Matching Mechanical Heterogeneity of the Native Spinal Cord Augments Axon
Infiltration in 3D-Printed Scaffolds
4.4.1. Microstructural Characterization of Spinal Cord Mechanical Properties
In order to examine the heterogeneity of spinal cord tissue, initial experiments using
AFM and tensiometry were conducted to interrogate differences in gray and white matter
along the transverse anatomical plane. Previous experiments have found that the gray
matter is stiffer than white matter in all anatomical plans (coronal, sagittal and transverse)
[130], though there is also conflicting evidence that no significant different between gray
and white matter exists [90]. To rectify the discrepancies between these studies, AFM and
tensiometry experiments were performed on the spinal cord (Fig. 29A,B).The tissue was
divided into three regions: sacral, thoracic/lumbar, and cervical to assess whether
anatomical level affected the mechanical properties of the cord. AFM revealed that the gray
matter exhibits significant higher elastic moduli compared to white matter, though there
were no statistical differences between the three levels (Fig. 29C). Post-hoc Tukey tests
indicated significant differences between gray and white matter at each level. Tensiometry
examined the relaxation factors of both gray and white matter by measuring stress
relaxation following indentation. Figure 29D shows the relaxation factors for both gray and
white matter in all three regions, and two-factor ANOVAs revealed a statistical difference
between the gray and white matter, though again there is no difference between levels.
Taken together, these results presented here indicate that the gray matter exhibits stiffer
and more viscoelastic mechanics compared to white matter, and that there is no difference
in the microstructural mechanical properties of gray and white matter along the length of
the cord.
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Figure 29. Microstructural mechanical properties of bovine spinal cord tissues. (A,B)
Schematic of atomic force microscopy (AFM) and tensiometer. (C) Measurements of
gray and white matter using AFM. (D) Relaxation factors of gray and white matter via
tensiometer. The box plots depict the median, 25 and 75 percentiles, and the whiskers
represent 1.5x the interquartile range. *p < 0.05 (n = 3).
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4.4.2. Macrostructural Mechanical Properties of Spinal Cord Tissue
Rheology was conducted to characterize bulk mechanics of the cord at cervical,
lumbar, and sacral levels. Given the results of the AFM testing, these experiments tested
the hypothesis that the disparity in bulk mechanical properties of anatomical levels is due
to differences in the ratio of gray-to-white matter. Therefore, shear storage and loss moduli
as well as cross-sectional area of gray and white matter were measured in 5-6-mm thick
transverse spinal cord sections taken from different levels. Figures 30A-C show rheological
experiments performed on three different bovine spinal cords. The highest storage and loss
moduli were measured in cervical regions of two of the animals and in the sacral region in
the third animal.
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Figure 30. Characterization of macrostructural mechanical properties of bovine
spinal cord tissues. Rheological experiments of cervical, lumbar and sacral regions
of spinal cords from 3 animals showing (A) storage modulus, (B) loss modulus and
(C) tan(δ). Data presented as mean ± s.e.m. (D-F) Images of spinal cords and (G-I)
quantification of gray-to-white matter ratios. The black lines indicate the
representative regions of quantified gray matter. Data presented as mean ± s.d. *p
< 0.05 (n = 3).
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Moreover, Figure 31 displays the sections were tested at increasing magnitudes of
compressive strain to determine whether the cord exhibits the compression stiffening
observed in other tissues [155], [156]. In order to reconcile the bulk testing with the AFM
measurements that found no difference in gray or white matter along the cord, transverse
spinal cord sections (Fig. 30D-F) were imaged and the percentage of gray matter in the
cross-section was expressed as a percentage of the total area (Fig. 30G-I). The gray matter
in the cervical region was significantly higher compared to the lumbar and sacral regions
in the experiment from the first two cords, and highest in the sacral region in the third
animal. Therefore, these results suggest that differences in the bulk rheological properties
along the cord are due to differences in the amount of the stiffer gray matter in the crosssection of the cord.

Figure 31. Compression stiffening effects of bovine spinal cord Rheological
experiments of cervical, lumbar and sacral regions of spinal cords from 3 animals
showing (A) storage modulus, (B) loss modulus and (C) tan(δ). Data presented as mean
± s.d.
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4.4.3. Microstructural Analysis of Gray and White Matter
In order to provide insight into structural differences between gray and white matter
that give rise to mechanical heterogeneity, immunohistochemistry was performed to
examine differences in cell nuclei and myelin expression in both regions. Sections from
the beginning and end of the experiment were analyzed to determine whether the cords
undergo substantial demyelination over the course of the experiment. Figure 3 shows
cervical sections fixed at the beginning (Fig. 32A) and end (Fig. 32B) of the mechanical
characterization experiments. These histological sections were stained for DAPI and
myelin to examine differences between gray and white matter. Quantification revealed
there is significantly higher DAPI staining in gray compared to white matter at both the
beginning and end of the experiment (Fig. 32C), which is consistent with a previous study
[130]. There was no significant difference between the myelin at the beginning of the
experiment compared to the end of the experiment, validating that the tissue did not
undergo substantial degradation during our testing (Fig. 32D) and suggesting that the
difference in gray and white matter mechanics is not due to differences in myelination.
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Figure 32. Immunohistochemical analysis of gray and white matter. (A) Images of
cervical sections fixed at the start of the experiment and (B) immunofluorescence
of sacral regions at the end of experiment. (C) Quantification of DAPI within the
gray and white matter at both the beginning and end of experiment. (D) Myelin
quantification normalized between gray and white matter at the beginning and end
of experiment. The box plots depict the median, 25 and 75 percentiles, and the
whiskers represent 1.5x the interquartile range. *p < 0.05 (n = 3).
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4.4.4. 3D-Printing a Heterogeneous Spinal Cord Scaffold
A novel DLP approach was developed to fabricate a scaffold that mimicked the
difference in stiffness between gray and white regions observed by microstructural
mechanical testing. Figure 33A shows a schematic of the printing method, which applies
varying levels of light intensity to a single z-plane using a grayscale mask. Grayscale
patterns were created to alter light intensity values between 0-100%, representing black to
white, to modulate the extent of polymerization of the GelMA hydrogel. In order to verify
this approach, test patterns of alternating intensity were printed in square blocks. Figure
33B shows the grayscale mask used for these preliminary prints, with stripes of 1-mm
thickness in a 10 x 10 x 3-mm block. Tensiometry was used to validate differences in
mechanical properties. Quantification of this data and subsequent statistical analysis reveal
significant differences between each stripe, demonstrating that the regions exposed to
higher light intensities exhibit stiffer mechanics than the regions with lower light intensities
(Fig. 33C). These results verify that heterogeneity can be achieved within the 3D-printed
scaffolds to mimic the difference in stiffness between gray and white matter regions.
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Figure 33. 3D-printing scaffolds with heterogeneity. (A) Schematic of grayscale
patterns to facilitate printing of a single plane with varying levels of light intensity. (B)
Preliminary 3D-printed hydrogels with heterogeneity. (C) Mechanical quantification of
each stripe within the 3D-printed hydrogels. Data presented as mean ± s.d. *p < 0.05 (n
= 3).
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4.4.5. Characterization of Heterogeneous Scaffolds Microstructure and Mechanical
Properties
Mechanical and microstructural assays were conducted to characterize the
heterogeneous spinal cord scaffolds, with regions mimicking gray and white matter.
Previous studies have shown that the stiffening effect in photocrosslinkable hydrogels
decrease dextran diffusivity, the porosity of these scaffolds was examined using a scanning
electron microscope (SEM). Figure 34A displays images of the gray and white matter
regions within the homogeneous and heterogeneous scaffolds. Quantification
demonstrated that the pore diameters were decreased as a result of the stiffening effect (Fig.
34B), which is consistent with a previous study [157]. In order to interrogate the mechanics
of gray and white matter within the 3D-printed scaffolds, compression tests were
performed on hydrogels that were exposed to higher pixel intensity to possess stiffer
mechanics compared to hydrogels that were crosslinked under lower light intensities.
Compression tests revealed that hydrogels exposed to the light intensity used to create the
gray matter region exhibited a significantly higher elastic modulus compared to hydrogels
representing white matter (Fig. 34C). Nonetheless, the compression indicated no
significant difference in the Poisson ratio of the hydrogels: both white and gray matter were
nearly incompressible ( ~ 0.4) (Fig. 34D). Having validated that there is a difference
between the mechanical properties of scaffolds exposed to different pixel intensities, two
hydrogel conditions were printed with a rat T10 geometry: homogeneous with the same
mechanics throughout the conduit and heterogeneous that exhibit stiffer mechanical
properties in the “butterfly” pattern to match the gray matter (Fig. 34E). Cylindrical
channels with diameters of 325 µm were added to the scaffolds due to their functional
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benefits of aligning axons along the rostral-caudal direction [23], [94]. Raster scans were
performed on the surface of these scaffolds to provide two-dimensional elasticity maps.
Figures 34F,G display representative elastic heatmaps in both the homogeneous and
heterogeneous scaffolds. Two-factor ANOVAs with post-hoc Tukey tests revealed that the
elasticity of the gray matter within the heterogeneous scaffolds exhibited significantly
higher Young’s moduli than the white matter of those scaffolds and the homogeneous
hydrogels (Fig. 34H). Taken together, the data presented here demonstrate that
heterogeneity in mechanics can be achieved using our 3D-printing approach to mimic
native tissue.
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Figure 34. Interrogation of 3D-printed heterogeneous scaffolds. (A) SEM images of
the gray and white matter in homogeneous and heterogeneous hydrogels. (B)
Quantification of porosity within the scaffolds. (C) Mechanical testing of 3D-printed
scaffolds that exhibit the mechanics of gray matter and white matter. (D) Poisson
ratios of 3D-printed scaffolds. (E) Brightfield images of 3D-printed scaffolds that
mimic the T10 level of rat’s spinal cord and exhibit homogeneous or heterogeneous
mechanics within the constructs. (F,G) Elasticity heatmaps of homogeneous and
heterogeneous scaffolds. (H) Young’s moduli in both the gray and white matter
within homogeneous and heterogeneous hydrogels. The data in the bar graphs are
represented as mean ± s.d. The box plots depict the median, 25 and 75 percentiles,
and the whiskers represent 1.5x the interquartile range. *p < 0.05 (n = 3).
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4.4.6. Assessing Axon Infiltration into Scaffolds with Heterogeneous Mechanical
Properties
Transplantation studies were then conducted to determine whether the
heterogeneous scaffolds would elicit increased axon infiltration compared to homogeneous
controls. Given that specific axonal tracts are located in the white matter [23], the
homogeneous scaffold exhibited mechanical properties that matched the “white matter” of
the heterogeneous scaffolds. Figure 35A displays a schematic of hydrogel fabrication,
injury

model

and

transplantation

of

the

implantation

of

T10

scaffolds.

Immunohistochemistry examined the infiltration of axons into the channels within the
white matter region of the transplanted scaffolds two weeks post-transplantation. The
presence of ascending sensory-specific tracts was measured using calcitonin gene-related
peptide (CGRP), a peptide widely expressed in sensory axons [140] (Fig. 35B).
Quantification of CGRP+ fibers demonstrated that heterogeneous scaffolds significantly
augmented the infiltration of sensory axons compared to the homogeneous conditions (Fig.
35C). To further assess axon infiltration into the scaffolds, both the rostral and caudal
regions of the transplanted scaffolds were examined for the presence of beta-tubulin III
(Tuj) fibers. Figure 35D displays the presence of Tuj+ axons located only in the rostral
region of the scaffolds with homogeneous mechanics. However, the infiltration and
outgrowth of Tuj+ fibers were observed in both the rostral and caudal sections of the
heterogeneous scaffolds (Fig. 35E), demonstrating that the mechanical heterogeneity
stimulated neuronal regeneration. In order to determine whether the stiffness disparity
stimulated axon growth, quantification of Tuj fibers was evaluated in the white matter
regions of both scaffold types and indicated that the heterogeneous scaffolds significantly
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promoted the growth of Tuj+ fibers (Fig. 35F) and stimulated the infiltration distance
compared to the homogeneous hydrogels (Fig. 35G). Overall, these results demonstrate
3D-printed scaffolds with heterogeneous mechanical properties matching the anisotropy of
host tissue have beneficial effects on the infiltration and regrowth of axons, providing the
basis for a new regenerative strategy to repair spinal cord injury.
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Figure 35. Examination of axon infiltration post-transplantation. (A) Schematic
showing scaffold fabrication to transplantation. (B,C) Immunofluorescence and
quantification of CGRP+ axons infiltrating the white matter of both the homogeneous
and heterogeneous scaffolds. (D,E) Infiltration of Tuj+ fibers within the cylindrical
channels located in the white matter in both scaffold conditions. Quantification of (F)
Tuj+ fibers and (G) infiltrating distance in the white matter in homogeneous and
heterogeneous scaffolds. The data in the bar graphs are represented as mean ± s.d. *p <
0.05 (n = 3).
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Chapter V
Discussion
5.1. Vascularization of Self-Assembled Peptide Scaffolds for Spinal Cord Injury
Repair
The results presented here suggest that the formation of BSCB-integrity
microvessels within a self-assembling RADA-16I hydrogel reduces inflammation and scar
formation at the site of a contusion SCI and increases axon infiltration into the injury site.
Although it's unclear whether the observed axons were sprouting and/or regenerating from
host spinal cord, the presence of the microvessels had a positive effect by either supporting
the viability of the spared axons or encouraging the growth of infiltrating axons. Given that
previous studies have demonstrated the ability of transplanted microvessels to anastomose
with host vasculature, it is possible that the microvessels benefit the injury site through the
delivery of oxygen and nutrients, though further studies are required to characterize
perfusion within these transplanted vessels. Nonetheless, recent studies have also showed
that vascular cells secrete neuroprotective factors [104], which is another possible
mechanism by which the transplanted microvessels can augment axon density. Regardless
of the underlying mechanism, the results of this work establish the benefit of transplanting
microvessels within a RADA-16I peptide hydrogel.
Previous studies have demonstrated the effectiveness of RADA-16I scaffolds to
incorporate with the damaged CNS and to be permissive to axon growth [37], [39], [46],
[158]. Our results support these previous findings by showing both axon infiltration and
strong incorporation with the host tissue in the acellular condition. Yet, our findings
indicate that the presence of microvessels significantly improves the performance of the
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peptide following transplantation. However, a caveat of this approach is the lack of
alignment of the microvessels prior to transplantation, given that a previous study has
found that transplanted microvessels can guide axon growth [8] and the results here suggest
that there is strong neurovascular interaction between general axons and the microvessels.
The reduced storage modulus of the peptide hydrogel precludes the ability to polymerize
the scaffold prior to transplantation, necessitating the injection technique described here.
Yet, exerting control over axonal orientation, specifically in the rostral-caudal direction, is
a substantial advantage for scaffolds to treat SCI. Therefore, future studies to control the
orientation of the microvessels that form within the peptide hydrogel are crucial. Patterning
vasculature within a permissive peptide scaffold like RADA-16I holds great promise for
an alternative treatment strategy to treat spinal cord injury.
Future work is also required to assess the functional benefits of transplanting
vascularized scaffolds into the site of spinal cord injuries. Although 5-HT staining was
used here to identify descending tracts and their interaction with the transplanted
microvessels, tracing of these tracts can provide further insight into the regenerative
response to the scaffolds. Beyond being limited by low sample numbers, the in vivo
experiments also involved the use of cyclosporine A to limit the immune response to the
transplanted scaffold and human-derived immortalized microvascular cells. Future
experiments can capitalize on recent methods to differentiate induced pluripotent stem cells
to tight junction forming cells [159], [160] to limit the immune response and conduct the
experiments in the absence of cyclosporine A. Lastly, more studies are required to
understand the dynamics of RADA-16I degradation following transplantation into the site
of spinal cord injury. Previous work has demonstrated that RADA-16I can be degraded
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through multiple routes [47]. In the current experiment, the scaffolds were assessed at a
single two-week time point, and therefore it is unclear how much and how quickly the
scaffold degrades during that time and whether the presence of the microvascular cells
accelerates remodeling and degradation of the transplanted scaffold.
Nonetheless, despite the limitations of the preliminary animal experiments
described here, the results establish vascularization as a general approach to improve
scaffolds for SCI repair. Our findings indicate that the presence of the microvessels
improves the secondary aspect of SCI, since both GFAP and ED-1 staining, markers for
activated astrocytes and macrophage/microglia respectively, were reduced in response to
cell-seeded scaffolds. Attenuating the detrimental effects of secondary injury and in turn
decreasing the size of the injury area has the potential to facilitate neuroregeneration, and
several other approaches including using chondroitinase ABC [161] and other enzymes to
degrade the scar have the same goal. However, the approach of delivering a vascularized
scaffold can potentially reduce scar formation while concurrently delivering nutrients and
oxygen to regenerating axons. Yet, in order to fully validate the strategy of vascularized
scaffolds for SCI repair, future studies must evaluate the functional benefit of these
scaffolds by quantifying the behavioral response of injured animals.
5.2. Magnetic Alignment of Injectable Hydrogel Scaffolds for Spinal Cord Injury
Repair
Both the in vitro and in vivo results of this work validate the strategy of using
magnetic fields to align fibrous matrices, and establish magnetic alignment of injectable
hydrogels as a means to provide topological cues to guide neurite growth in the damaged
spinal cord. Although previous studies have demonstrated that fiber alignment can be
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manipulated by magnetism in various scaffolds [17]–[19], [21], the findings presented here
demonstrate the validity of this approach to in vivo applications. The results show that
magnetically aligned peptide hydrogels provide topological cues as guidance for axon
alignment in vitro, and that this method of post-injection alignment can be applied to spinal
cord injury. Magnetic alignment creates an anisotropic environment that is physiologically
relevant to the native ECM of the spinal cord since previous results have determined the
importance of aligning structures in the rostral-caudal direction [32], [54]. Our findings
highlight the biocompatibility of MP-seeded scaffolds on cell viability via in vitro studies
using co-cultures of hMSCs and NPCs to assess axon growth and in vivo experiments to
quantify host axon infiltration. Taken together, the results demonstrate the benefits of postinjection alignment through magnetism to rapidly facilitate fiber orientation.
In addition to verifying the ability of magnetic fields to align fibrous matrices
following transplantation, the results also suggest that cell therapies augment the
regenerative effects of magnetic alignment. Although previous studies have shown that
topology harnesses physical cues to control neurite extension along the direction of
alignment [162]–[164], the presence of hMSC provides a complementary effect on
supporting the growth of infiltrating axons and amplifying axon alignment. The BDNF
ELISA results reveal that the additive effects of scaffold alignment and hMSC seeding
significantly increases the production of the neurotrophic factor in vitro. Future studies are
needed to determine whether the hMSC-seeded scaffolds encourage axon infiltration
through BDNF secretion in the animal model. In addition, further studies will interrogate
whether the increase in axonal alignment and growth causes a functional benefit as well.
Nevertheless, the results here exhibit the benefits of combining magnetic alignment with
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cell-seeded scaffolds to encourage axons to regrow into the injury site in the rostral-caudal
direction.
The ability to align hydrogel fibers from outside the body distinguishes this
approach from previous means to modify scaffolds in vivo. Previous studies have evaluated
various complex light- and pH-sensitive hydrogel platforms as potential therapies for tissue
engineering. However, tissue density prevents light from penetrating into various areas of
the body such as the skull and spine [62], [74], [75], [129]. Here, we demonstrate the ability
to align scaffold fibers with magnetic fields, which are not limited by the restrictions of
UV-light used for photocrosslinkable hydrogels [62], [165], [166]. Magnetic fields can
conceivably be applied during transplantation in human patients, though future studies are
required to determine potential issues involved with clearance of carbonyl iron
microparticles and long-term remodeling of the scaffold. Furthermore, this work also
facilitates future studies interrogating the use of magnetic fields to dynamically tune ECM
mechanics in vivo. Previous work has found that glial scars exhibit lower stiffnesses than
surrounding tissue in the days and weeks following CNS injury, which may contribute to
neurodegeneration [165]. Our previous results have demonstrated that scaffold mechanics
can be rapidly and reversibly altered by applying and removing an external magnetic field
to control astrocyte morphology and mechanotransduction [166]. Thus, injecting hydrogels
seeded with MPs into the nervous system can potentially be used to tune mechanical
properties to encourage neuroregeneration. Therefore, these results identify a new strategy
to tune both the mechanics and alignment of scaffolds for spinal cord recovery.
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5.3. Dynamic Tuning of Protein Hydrogel Mechanics with Carbonyl Iron
Microparticles Guides Three-Dimensional Cell Mechanotransduction
The results presented here demonstrate that magnetic tuning of hydrogel mechanics
yields a new means to study cell mechanobiology in 3D environments. One of the
advantages of using MPs to dynamically alter 3D hydrogel mechanics is the ability to
generalize this approach across multiple hydrogel systems and platforms. Several recent
studies have examined the magnetorheological properties of MPs embedded in various
hydrogels including carrageenan [79], [167], alginate [168] and acrylamide [82]. Here, we
demonstrate that the stiffness of several different hydrogel formulations (collagen, fibrin,
collagen-hyaluronan) compatible with multiple different cell types (smooth muscle cells
and astrocytes) can be altered without any modification to crosslinking chemistry or ligand
density. Therefore, researchers using in vitro systems to study cell mechanobiology in 3D
geometries can use MPs to dynamically alter ECM mechanics by the simple application of
a magnetic field. Showing that the magnetic field does not cause measurable displacement
of the MPs after gel polymerization suggests that the pore size and microstructure of the
hydrogel is not altered, indicating that the magnetic field changes hydrogel mechanics
independent of any effect on ligand density or topology. Therefore, magnetically active
hydrogels can complement the complex light- and pH-sensitive approaches that have been
used previously [74], [75], [129], which all require specific chemistries and substrates,
providing a broadly adaptable alternative [169], [170]. The results presented here mirror
several results from studies using photo-crosslinkable chemistries, specifically the inability
of cells to spread within hydrogels exhibiting storage moduli that exceed 10 kPa [74],
[129]. But they also demonstrate the potential for magnetically tunable hydrogels to
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provide new insight into the dynamics of cell mechanotransduction, showing that cells
allowed to spread in a lower stiffness environment increase their nuclear translocation of
YAP as the hydrogel becomes stiffer and instantaneous alteration of ECM mechanics
results in immediate changes to calcium handling within cells in 3D.
The near-instantaneous effect of magnetic stiffening and its rapid reversibility
distinguish this approach from previous means of dynamically altering 3D substrate
mechanics. As shown in the rheological tests, removal of the magnetic field returns the
hydrogel to its original mechanical properties nearly instantaneously. The analytical model
and confocal microscopy experiments provide some insight into the mechanisms
underlying these effects. In the presence of a magnetic field, the MPs likely form dipoles
that resist any motion relative to adjacent particles. The application of an external
mechanical stimulus causes the ferromagnetic particles to become misaligned and results
in antisymmetric stresses, and thus contributes to the increase of shear modulus as
demonstrated in rheological studies. Due to the stiffening effect, this resistance gives rise
to the increase in hydrogel stiffness in the presence of the magnetic field, and also explains
how removal of the magnetic field returns the fibrous networks to their original state.
Previous studies that have demonstrated the concentration of carbonyl iron MPs
substantially affect the stiffness of the hydrogel conclude that particle dispersibility
contributes to a drastic change in elastic modulus compared to highly organized magnetic
chains [79], [80], which supports this proposed mechanism. The rheological data and live
cell experiments, which represent the global and local application of force respectively,
both demonstrate that MP displacement is impeded in the presence of magnetic fields and
subsequently stiffen the fibrous network. Thus, removing the magnetic field abruptly ends
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the stiffening effect, yielding a means to transiently and reversibly alter hydrogel
mechanics.
The rapid and reversible nature of magnetic stiffening provides new insight into
both short-term and chronic characteristics of the cell response. As evidenced by the
calcium transient studies, smooth muscle cells respond to the stiffness of the surrounding
matrix within seconds by altering the rate of calcium influx and period of the calcium
transient. The MR hydrogels therefore provide a platform for future studies to interrogate
the underlying molecular mechanisms by which cells sense the mechanics of their
environment and alter calcium handling and actomyosin force generation within very short
time scales. The morphology and YAP measurements in astrocytes also demonstrate how
this technique can be used to study longer term aspects of the cell response. A previous
study has shown that cells readily uptake magnetic microparticles with diameters as large
as 5.8 µm without affecting cell function [171]. Therefore, the effect of dynamic stiffness
on gene expression can be evaluated by probing the transcriptional state of the cells in
hydrogels undergoing controlled changes in rheological properties. In this way, magnetic
hydrogels provide a new means to study cell-ECM interactions in the context of various
tissues. There are several physiological and pathological processes involving timedependent changes to ECM mechanics that can be mimicked by dynamic and reversible
modification of hydrogel stiffness: cardiac fibrosis [172]–[174], wound healing [175],
[176], tumor metastasis [177], [178], and atherosclerosis [179], [180] are all relevant
examples. Beyond the time-dependent studies presented here, focusing of magnetic fields
within sub-millimeter loci can create well-defined spatial gradients. Therefore, MP-seeded
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hydrogels can interrogate the effects of local stiffening within 3D in vitro blood vessel
models and other microfluidic applications.
There is also the potential to use protein-based MR hydrogels in applications related
to tissue engineering, given the cytocompatibility of the MPs [78], [82] and the ability of
magnetic fields to penetrate further into tissue than the UV light used for
photocrosslinkable chemistries [62], [165], [166]. There is specific relevance for central
nervous system (CNS) injury, given the results related to controlling astrocyte morphology
and YAP translocation to the nucleus. Previous studies have found glial scars that form in
the aftermath of CNS injury exhibit a lower stiffness than surrounding tissue, which may
affect neuroregeneration [16]. Implanting hydrogels seeded with MPs into the cord
provides a means to dynamically alter the stiffness of the scaffold during the healing
process to encourage axon infiltration and outgrowth from the injury area. Due to the
presence of the skull and spine, the CNS is also a good example of a tissue that would not
be compatible with UV-photocrosslinkable means of tuning scaffold mechanical properties
[62]. Overall, the flexibility of magnetic hydrogels amplifies its potential use for both in
vitro and in vivo applications.
5.4. Matching Mechanical Heterogeneity of the Native Spinal Cord Augments Axon
Infiltration in 3D-Printed Scaffolds
The results demonstrate that mimicking the stiffness disparity between gray and
white matter in an implantable scaffold encourages axon growth at the site of a rat spinal
cord transection injury. Previous studies have demonstrated that multicellular migration is
enhanced along a gradient in the rigidity of the extracellular matrix, referred to as durotaxis,
in both in vivo [181] and in vitro [182], [183] microenvironments. In contrast, the stiffness
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gradient used here is orthogonal to the direction of axonal growth, though this gradient is
more representative of native spinal cord tissue. The mechanical testing conducted in this
work indicates that the inner gray matter is stiffer than the surrounding white matter in the
cord, and the mechanics of the cord do not change along the rostral-caudal axis. The
primary goal of a spinal cord scaffold or conduit is to encourage axon growth in the rostralcaudal direction to restore connectivity across the site of injury, since axon tracts are
primarily aligned in this direction [23], [32], [103]. Therefore, the axons infiltrating the
scaffold are not growing along a rigidity gradient, but like axon tracts in native tissue, they
are growing perpendicular to a disparity in matrix stiffness. Consequently, the mechanisms
underlying increased axon infiltration in heterogeneous scaffolds compared to
homogenous controls are likely different than those identified in previous durotaxis studies,
including specific cell-matrix interactions [184], [185] and small GTPase-mediated
actomyosin contractility [186]–[188]. Future studies are therefore required to understand
the molecular mechanisms responsible for the increased axon growth into the
heterogeneous scaffolds.
The modification to digital light processing described here enables 3D-printing of
complex topologies within mechanically heterogeneous hydrogels. DLP is a powerful tool
for recreating complex tissue architectures in hydrogels, though previously the method has
been limited to printing scaffolds exhibiting homogenous mechanics. However, other
existing 3D-printing approaches are capable of printing interfacial and heterogeneous
structures. For example, extrusion-based methods have been used to create heterogeneous
aortic valve scaffolds [189]. But these methods are not applicable to softer, cell-permeable
hydrogels, which are more appropriate for printing scaffolds with mechanics that match
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soft tissue like the spinal cord. And although 3D-printed scaffolds with elastic moduli
greater than 200 kPa have been implanted within the spinal cord and demonstrated axon
infiltration [23], DLP can recreate native tissue topology while also incorporating cellbased therapies by creating cell-permeable scaffolds with elastic moduli less than 10 kPa.
Therefore, advancing DLP technology to print hydrogels with spatially varying mechanics
provides a pathway to create scaffolds that better mimic the anisotropy of a variety of native
tissues, and specifically to harness durotaxis by fabricating hydrogels that control cell
growth and migration.
As advances in 3D-printing technology are made to mimic native tissue, one
limitation to fabricating scaffolds that recreate the in vivo microenvironment is our
understanding of complex tissue mechanics. Tissue mechanical properties are a function
of multiple length scales, creating heterogeneity that is difficult to characterize and then
implement in 3D-printed constructs. In this specific aim, a variety of mechanical testing,
including rheology and atomic force microscopy, characterize spinal cord tissue ex vivo.
These studies indicate that the macroscale mechanical properties of the spinal cord change
as a function of level. Although previous work has shown that the mechanics of the cord
are different based on the type of sectioning (e.g. coronal, sagittal, or transverse) [130],
these results are the first to find differences in mechanical properties along the cord.
Combining macroscale with microscale mechanical testing indicated that although the bulk
mechanics differ along the cord, the mechanics of white matter and gray matter remain
constant and gray matter is stiffer than white matter. Therefore, the differences in
rheological properties arise from differences in the percentage of gray matter in the coronal
section and not intrinsic disparity between levels. These findings justify the DLP-based
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approach to fabricate scaffolds that recreate a stiffer inner region to mimic the difference
in gray-white matter mechanics. However, one aspect of the spinal cord tissue mechanics
that the scaffolds do not mimic is viscoelasticity: the GelMA scaffolds are primarily elastic
even though tensiometry indicated that gray matter exhibited higher stress relaxation.
Therefore, there is a need for photoinks with tunable viscoelasticity, especially for tissues
like the spinal cord that exhibit these properties.
Nonetheless, the DLP approach described here has the flexibility to incorporate
existing neurotrophic therapies. As mentioned, in contrast to other 3D-printing approaches,
the GelMA scaffolds printed for these studies are compatible with cell seeding. There are
currently ongoing clinical trials evaluating the efficacy of intrathecal injection of
mesenchymal stem cells (MSC) in spinal cord injury patients [59], with evidence that
MSCs release neurotrophic factors to stimulate axon growth and connectivity. Therefore,
future studies will interrogate the benefit of incorporating MSCs into the heterogeneous
scaffolds following implantation at the site of injury. In contrast to intrathecal injection,
this approach can augment the residence time for MSCs at the site of injury and determine
whether longer retention is beneficial. Moreover, the composition of the scaffold is also
tunable. Although GelMA is used here, the DLP approach is compatible with other
photoinks. Therefore, printing heterogeneous mechanics in degradable [190] or electrically
conductive[105] photoinks provides a new means to combine different aspects of
regenerative approaches in a multifunctional scaffold that mimics the mechanical
anisotropy of native tissue.
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5.5. Conclusion, Impact, and Outlook
While bioengineered scaffolds have been extensively studied, the techniques and
results described in this dissertation yield numerous biological insights that can inform
therapeutic strategies for spinal cord injury repair. The primary findings of the specific
aims are as follows:
1. Self-assembled

peptide

hydrogels

support

neuronal

regeneration,

and

vascularization of these scaffolds augments axon infiltration and attenuates
inflammation and astrogliosis.
2. Injectable, magnetically-responsive peptide hydrogels provide rostral-caudal
guidance cues, and the incorporation of mesenchymal stem cells increases axon
regrowth through BDNF secretion.
3. 3D-printed scaffolds with heterogenous mechanical properties that mimic the gray
and white matter promote regeneration of axons in a transection spinal cord injury
model.
The results from these experiments demonstrate the potential translational benefit
of bioengineering scaffolds to repair spinal cord injury. Fabricating injectable hydrogels
with rostral-caudal alignment and 3D-printing scaffolds with mechanical anisotropy both
promote axon regrowth. Moreover, the transplantation of cell-seeded scaffolds exhibits
primary and secondary benefits in promoting axon infiltration and attenuating
inflammation in both injectable and solid scaffolds. These two modalities of bioengineered
scaffolds provide physical guidance cues to control host axon infiltration along the rostralcaudal direction, which is the native orientation of the spinal cord. Overall, the novel
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techniques developed in this dissertation create the foundation for new regenerative
strategies to repair the damaged spinal cord.
Although the work advances the field of tissue engineering and regenerative
medicine, there are still several caveats that must be addressed in future studies:
1. The magnetic particles can become oxidized and cytotoxic to the cells within
the matrix. Future experiments will be needed to interrogate biocompatible
coatings of particles that do not affect any magnetic or rheological properties.
2. Since 3D-printed scaffolds with mechanical heterogeneity have shown to
improve axon infiltration, future approaches will needed to incorporate cells
within these constructs.
3. Since gelatin-methacrylate (GelMA) is derived from a bovine source, there is a
need for biomaterial innovations to create photocrosslinkable scaffolds with
synthesized peptides. Additionally, GelMA is predominantly linearly elastic,
but our results show that spinal cord tissue is viscoelastic. Future experiments
will be needed to tune the viscoelasticity of 3D-printed scaffolds to fully mimic
the mechanical properties of native tissue.
4. The 3D-printing techniques described in this dissertation indicate axon
infiltration, but likely not enough to result in functional improvements
following injury. Future experiments will need to investigate the ability to
incorporate additional strategies such as conductive polymers to improve the
efficacy of transplanted scaffolds.
While the current work demonstrates that magnetic fields facilitate rostral-caudal
alignment, future experiments will need to interrogate the long-term effects of embedding
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magnetic particles in RADA-16I. One aspect of improving magnetically-responsive
biomaterials is to functionalize magnetic particles with a protective polymer to optimize
cell viability. Previous studies have demonstrated the ability to coat the particles with either
silica or polystyrene without diminishing the rheological effects to maintain the cell
viability within the fabricated scaffolds [191], [192]. These studies would facilitate longterm spinal cord studies for behavioral analysis. Despite the lack of behavioral analysis
presented in this dissertation, future experiments can be designed to perform the Louisville
Swim Scale (LSS) as a novel assessment of hindlimb function for rats that undergo
contusion spinal cord injuries [193].
The benefits of incorporating both vascular and mesenchymal stem cells in our
scaffolds suggest that cells should also be incorporated in the 3D-printed constructs with
mechanical heterogeneity. The ability to harvest and generate custom constructs using a
patient’s own cells can prevent a host inflammatory response during transplantation. Future
clinical work can isolate mesenchymal stem cells directly from patients to incorporate with
our magnetically-aligned injectable or 3D-printed platforms for cell-scaffold-based
therapies to repair the spinal cord. Moreover, future techniques can explore the fabrication
of functional scaffolds by 3D-printing blood-brain barrier vasculature to provide the
required nutrients for sustained axon proliferation. The results from the first specific aim
demonstrate the primary and secondary benefits of transplanting microvessels, but
vascularizing 3D-printed scaffolds on a capillary scale has yet to be achieved due to
limitations in the printability of the device. As the field of 3D-printing advances,
refinement of printing resolution can be used to generate microvasculature in the scaffolds.
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While the approach described in this dissertation often relies on gelatinmethacrylate (GelMA), synthesizing new peptide-based bioinks for 3D-printed constructs
would eliminate the need for bovine-sourced gelatin. Novel chemistries that provide more
flexibility in hydrogel mechanical properties and allow for tuning of cell-matrix
interactions can potentially improve the regenerative capability of 3D-printed scaffolds.
Another caveat to GelMA bioinks is that they are linearly elastic, whereas the mechanical
testing data showed that the spinal cord tissue is viscoelastic. Future studies can incorporate
gellan gum, a polysaccharide able to tune the loss angle of the hydrogel without
significantly changing the storage modulus. Future studies can determine whether
mimicking the viscoelastic properties of native tissue can increase axon infiltration into the
scaffold.
While we have developed a novel technique to 3D-print mechanical heterogeneity
within the constructs, there are ongoing efforts to develop functional bioinks that can
provide an electrically conductive microenvironment. Conductive polymers have been
traditionally used in a wide variety of tissue engineering applications (bone, cardiac, nerve
and muscle) [105]. In terms of spinal cord injury, previous studies have demonstrated that
transplantation of microfibers with electrically active polymers (PEDOT:PSS) augments
blood vessel formation and axonal regeneration while reducing astrogliosis. Combining
conductive bioinks with the ability to fabricate heterogeneous mechanical properties
scaffolds holds great promise for a multifunctional scaffold to repair the damaged spinal
cord.
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Appendix
Oxygen Gradients Dictate Angiogenesis But Not
Barriergenesis in a 3D Brain Microvascular Model
Abstract
A variety of biophysical properties are known to regulate angiogenic sprouting, and
in vitro systems can parse the individual effects of these factors in a controlled setting.
Here, a three-dimensional brain microvascular model interrogates how variables including
extracellular matrix composition, fluid shear stress, and radius of curvature affect
angiogenic sprouting of cerebral endothelial cells. Tracking endothelial migration over
several days reveals that application of fluid shear stress and enlarged vessel radius of
curvature both attenuate sprouting. Computational modeling informed by oxygen
consumption assays suggests that sprouting correlates to reduced oxygen concentration:
both fluid shear stress and vessel geometry alter the local oxygen levels dictated by both
ambient conditions and cellular respiration. Moreover, increasing cell density and
consequently lowering the local oxygen levels yields significantly more sprouting. Further
analysis reveals that the magnitude of oxygen concentration is not as important as its spatial
concentration gradient: decreasing ambient oxygen concentration causes significantly less
sprouting than applying an external oxygen gradient to the vessels. In contrast,
barriergenesis is dictated by shear stress independent of local oxygen concentrations,
suggesting that different mechanisms mediate angiogenesis and barrier formation and that
angiogenic sprouting can occur without compromising the barrier. Overall, these results
improve our understanding of how specific biophysical variables regulate the function and
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activation of cerebral vasculature, and identify spatial oxygen gradients as the driving
factor of angiogenesis in the brain.
Introduction
The brain is a highly metabolically active organ that accounts for 20% of the body’s
total oxygen consumption despite only accounting for approximately 2% of total body
weight [194]. It has a heterogeneous topography of local metabolic requirements dictated
by neuronal density and activity [195], and precise regulation of blood flow to supply
oxygen and nutrients is vital for proper functioning of brain tissue. While most endothelial
cell subtypes in other parts of the body rely heavily on glycolysis for energy production
[196], cerebral endothelial cells, which form tight junctions that give rise to the blood-brain
barrier, contain a greater concentration of mitochondria that produce energy via oxidative
phosphorylation [197]. This difference suggests that cerebral endothelial cells may be more
sensitive to changes in local oxygen concentrations than in other tissues. Recent studies
have shown that even mild levels of hypoxia can lead to blood-brain barrier disruption and
subsequent angiogenesis in mice [198], but the relationship between oxygen tension and
cerebral endothelial function has yet to be directly interrogated in a controlled, in vitro
environment.
Hypoxia occurs in physiological processes including development as well as a
broad range of pathologies that encompasses cancer and stroke [199]. Hypoxia is generally
associated with an increase in angiogenesis through activation of hypoxia inducible factors,
which in turn regulate the transcription of pro-angiogenic factors [200]. In systemic
vasculature, and specifically during processes related to cancer, angiogenesis is generally
associated with increased vascular permeability due to the effects of proteins like vascular
endothelial growth factor (VEGF) [201]. However, increased permeability in the brain has
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severe consequences: blood-brain barrier disruption leads to inflammation and subsequent
damage to the surrounding parenchyma [202]. Previous studies have shown that
angiogenesis and barriergenesis can occur simultaneously in the developing brain so that
new blood vessels can sprout from existing vasculature without allowing transport of blood
components into the extracellular matrix of the central nervous system [203]. However, the
factors that mediate angiogenesis and barriergenesis in cerebral vasculature during both
development and disease remain mostly unclear.
In recent years, in vitro models of vasculature have provided tremendous insight
into angiogenesis and the formation of neovasculature in controlled, three-dimensional
environments. In contrast to tubulogenesis assays on two-dimensional substrates, 3D
systems can capture the cell-matrix interactions that mediate sprouting and neovessel
formation. The effects of both biochemical factors [133], [204], [205] and mechanical
stimuli [127], [206]–[212] on angiogenesis have been extensively investigated in these
systems. The primary advantage of 3D models, despite not fully recapitulating the in vivo
microenvironment, is their ability to precisely control environmental factors to provide a
mechanistic understanding of pro-angiogenic processes. These systems have also been
used to assess the angiogenic response to hypoxia [213], demonstrating that hypoxia
influences the effects of other factors that stimulate neovessel formation. The recent
development of 3D models of the blood-brain barrier provides a means to interrogate the
effect of hypoxia and other factors on both angiogenesis and barriergenesis in a controlled
environment.
Another advantage of 3D in vitro models is their compatibility with computational
modeling to predict spatial and temporal distributions of angiogenic factors exposed to
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endothelialized vessels. Complex computational models have been developed to predict
the angiogenic response to interstitial fluid flow by coupling convective and diffusive
transport with constitutive equations predicting cell division and migration [209], [214]–
[216]. Coupling finite element simulations of oxygen transport with experimental data has
previously been used to predict cell viability within in vitro systems [125]. An important
component of oxygen tension models is the prediction of cellular oxygen consumption,
which serves as a major sink in the diffusive constitutive equation. There has been
substantial innovation in systems to directly measure cellular oxygen consumption
including microfluidic-based approaches [217]. Accurate measurements of oxygen
consumption are vital to informing computational models of oxygen diffusion within in
vitro systems, and previous studies have provided measurements of oxygen consumption
by cerebral endothelial cells in culture [218]–[220]. Overall, combining in vitro platforms
with computational models informed by cellular oxygen consumption rates can provide
new insight into processes affecting angiogenesis and barriergenesis in cerebral
vasculature.
Materials and Methods
Microfabricated devices and hydrogel preparation
Polydimethylsiloxane (PDMS) microfluidic devices were fabricated using soft
lithography [124], [186]. Briefly, positive features were used to cast negative features and
a layer of PDMS was used to enclose the devices. The hydrogel reservoir was filled with 5
M sulfuric acid for 90 minutes, washed thoroughly with deionized water, and coated with
20 µg/mL collagen for 60 minutes. All microfluidic devices were sterilized using
shortwave length ultraviolet light prior to use. Collagen hydrogels were formed within
reservoirs in the device by mixing solubilized collagen in 0.02 N acetic acid with 10X PBS,
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0.1 M NaOH, 1 mg/mL of Matrigel and deionized water to yield a final concentration of 2
mg/mL [125], [221]. For gels containing hyaluronan (HA), the deionized water was
replaced with 2-2.4 MDa HA to create a final mixture of 1 mg/mL HA, 1 mg/mL Matrigel
and 2 mg/mL collagen [126], [186].
Cell culture
P22-23 human cerebral microvascular endothelial cells (HCMEC/d3) were cultured
in gelatin-coated culture plates prior to use in experiments. Modified endothelial growth
medium (EGM-2) was prepared using a previous protocol [222]. The final concentrations
of EGM-2 yielded the following: 5 µg/mL ascorbic acid (Sigma), 1 ng/mL bFGF
(Peprotech), 1% chemically defined lipid concentration (Thermo Fisher) 5% fetal bovine
serum (FBS) (VWR), 10 mM HEPES buffer (VWR), 1.4 µM of hydrocortisone (VWR),
and 1% penicillin-streptomycin (VWR). HCMEC/d3 were thawed 5 days prior to seeding
and medium was changed every other day.
3D angiogenic model
Three-dimensional blood vessels were fabricated using a previously described
protocol [124], [186]. Briefly, 60 µL of collagen gel was injected into the hydrogel
reservoir of the device and either 180-µm or 300-µm diameter acupuncture needles coated
with 0.1 % BSA were inserted prior to polymerization. The needles were removed after the
hydrogel polymerized to create 2 parallel cylindrical channels in which HCMEC/d3 cells
were injected into one channel at a density of 5 × 106 cells/mL. For high-density 300-µm
blood vessels, cells were seeded at a density of 20 × 106 cells/mL. The endothelialized
channels were incubated for 10 minutes on each side to ensure cell attachment. Following
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cell seeding, these channels were either exposed to static conditions or perfused with
culture medium using a linear syringe pump (Kent Scientific) for 4 days.
Hypoxia experiments
Blood vessels fabricated in 300-µm channels were cultured with EGM-2 in static
conditions in a 1% O2 hypoxic chamber by purging with nitrogen for 4 days while
maintaining 37°C and 5% CO2. To create an oxygen gradient in a hypoxic incubator, a
syringe pump containing EGM-2 was placed outside the incubator and injected the medium
into the adjacent channel at a fixed rate of 2.4 µL/min for 4 days.
Immunocytochemistry
Microfluidic devices were fixed with 4% paraformaldehyde (Alfa Aesar) for 20
minutes and permeabilized with 0.2% Triton X-100 (Sigma) for 20 min at room
temperature. For ZO-1 labeling, hydrogels were removed from the devices and blocked by
3% bovine serum albumin (BSA) for 30 min at room temperature. These gels were
incubated with 1:250 anti-ZO-1 (Cell Signaling) for 48 hours at 4°C. These gels were
washed thoroughly with PBS and all secondary antibodies were used at 1:500 dilution. Cell
nuclei were identified with DAPI (1:500) and F-actin was stained using Alexa Fluor 488conjugated phalloidin at 37°C for 60 minutes.
Sprout quantification
Images of the vessel walls were converted to 8-bit image files, rotated, and cropped
to a height of 999.81 units so that the sprouts emanated from the right side of the image. A
custom MATLAB program converted the image to a binary matrix with a gradient mask.
Based on the final binary mask image, a new matrix was generated. The sprout frequency
for each vessel wall was determined by calculating the percentage of the vessel border
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exceeding a threshold distance of 40 microns from the parent microvessel to include only
mature sprouts. The algorithm was also utilized to evaluate the normalized average sprout
length, standard deviation, root mean square, and maximum length of the sprouting in each
vessel wall.
Glucose Measurements
To measure the glucose concentrations within each vessel condition, 15-µL of
media was removed from 300-µm diameter vessels (both low and high density) after 4 days
of incubation. Test strips compatible with a OneTouch glucometer were used to determine
the amounts of glucose in the media and measurements were performed in triplicates for
each condition.
Permeability testing
Blood vessels exposed to experimental conditions were transferred to a stage of an
inverted epifluorescent microscope enclosed by an environmental chamber. Using a
syringe pump, 4-kDa FITC dextran was perfused into the channels at a flow rate of 5
µL/min for 10 minutes while submerged in culture medium to maintain cell viability.
Images were taken at 30-s intervals, and the permeability coefficients were calculated using
𝑑𝐼 𝑟

the following equation [60], [223]: 𝑃 = 𝑑𝑡 2𝐼 where dI/dt is the change in intensity over
𝑜

time, r is radius of the blood vessel and Io is the maximum intensity.
Oxygen consumption assay (OCR)
Oxygen consumption rate assay kits (Cayman Chemicals) were used to measure the
relative amounts of oxygen consumed within each vessel condition. Due to the nature of
the small cylindrical channels, we could not control the exact number of cells seeded within
the channel for a given cell density injected into the device. Thus, in order to determine the
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number of cells lining the channel walls, DAPI images were obtained and cell nuclei were
counted within each vessel condition. The cell densities for the OCR assays were then
chosen to replicate these measurements: 10,000 cells/well as a reference, 129,408
cells/well (180-µm), 112,704 cells/well (300-µm, low density) and 175,296 cells/well
(300-µm, high cell density). HCMEC/D3s were plated in a 96-well plate for 2 hours to
form a 2D monolayer, since the assay was not compatible with the 3D model. Once the
monolayer was formed, culture medium supplemented with 10-µL of phosphorescent
oxygen probe was added and oxygen consumption was measured over a time span of 30
minutes. These relative rates were then compared to previously published values to provide
absolute quantities [218], [219].
Computational modeling
In order to predict oxygen distributions within the hydrogel containing the 3D brain
microvascular model, a finite element model was constructed using commercially available
software (COMSOL). A schematic of the microfluidic device and the location of the
collagen gel within the device is shown in Supplemental Figure A1A. The geometry of the
collagen gel was imported into the finite element software and boundary conditions were
applied. The cellular channel was modeled as a 5-µm-thick annulus as shown in
Supplemental Figure A1B; the diameter of the acellular and cellular channels was set to
either 180 or 300 µm depending on the experiment. A constitutive equation for Fick’s
second law was solved over the discretized geometry (triangular mesh elements):
∇∙J=R
where J is the flux vector and R is the reaction rate.
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Boundaries in direct contact with culture medium were set as fixed concentration
to 21% oxygen (9.4 mol/m3). The cellular annulus was set as a 0th-order volume reaction
term with consumption rates obtained from the OCR for different cell seeding densities.
The remaining boundaries were considered no flux (Supplemental Figure A1C). The
oxygen diffusion coefficient was set at 4.5 x 10-10 m2/s within the collagen gel, using a
value obtained from a previous study [224].
In the hypoxic gradient experiments, when medium is perfused through the
acellular channel, the boundary in the acellular channel is fixed at 9.4 mol/m3. The Peclet
number of the flow in the hypoxic gradient (300 µm diameter vessel and 5 µL/min flow
rate) was approximately 8000, indicating convection dominates diffusion and the use of a
constant concentration boundary condition.
Statistics
Two-way ANOVA and post-hoc Tukey’s HSD tests were performed to calculate
statistical differences unless otherwise specified. For the hypoxic experiments, a Welch
Two Sample t-test, assuming normal distributions with unequal variances between groups
was used to calculate significant differences. P-value less than 0.05 indicated significant
differences. Measurements from each condition were averaged from n = 3 or greater.
Results
I. The effect of ECM composition and fluid flow on angiogenic sprouting
A primary advantage of the three-dimensional brain microvascular model is its
ability to control specific biophysical variables in order to probe their effect on angiogenic
sprouting. These studies interrogated the effects of both HA concentration in the collagen
hydrogel and the application of fluid shear stress to the endothelial cells. Previous studies
have shown that the addition of hyaluronan slows down the rate of polymerization of
167

collagen hydrogels without affecting their equilibrium storage moduli, thus these
experiments did not evaluate the effect of matrix mechanical properties on sprouting [125].
In order to quantify angiogenesis, a MATLAB code was written to measure the percentage
of the vessel experiencing angiogenic sprouting for four days following cell seeding.
Although maximum sprout length was initially calculated, sprouting frequency provided a
more representative estimation of angiogenic activity along the length of the vessel in the
bulk of the hydrogel. Figures A1A and A1B show the entire 3D brain microvascular blood
vessels exposed to static and flow conditions. Figures A1C and A1D focus on the edge of
phalloidin-stained vessels in collagen-only hydrogels after four days in two orthogonal
planes. A shear stress of 0.7 dyn/cm2 was chosen based on previous studies demonstrating
this magnitude causes barriergenesis [124] and is lower than the threshold that induces
angiogenesis in HUVEC-lined channels [127]. Shear stress substantially reduced sprouting
from the vessel, though there were regions of the vessel exhibiting endothelial migration
into the surrounding matrix (Figure A1D,ii). Figure A1C,ii (white arrow) shows the
presence of small lumens in the sprouting structures in the static condition, indicative of
early neovessel formation that is not observed in the flow condition (Figure A1B,ii). The
addition of hyaluronan into the matrix did not affect sprouting in both static and flow
conditions (Figures A1E,A1F). Again, only the static vessels featured lumens in the
sprouting structures. Two-factor ANOVA analysis confirmed that the addition of flow but
not hyaluronan significantly affected sprouting from the endothelial vessels (Figure A1G).
II. Evaluating the effect of biophysical factors on oxygen concentration
In addition to exerting shear stress to the endothelial cells lining the vessel, the
application of fluid flow also alters local oxygen tension by constantly replenishing the
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oxygen concentration within the cell-seeded channel. In static conditions, cellular oxygen
consumption reduces the local oxygen concentrations. In order to determine whether the
primary anti-angiogenic effect of fluid flow is either by application of shear stress or by
altering oxygen tension, endothelial cells were seeded within a larger diameter (300 µm)
vessel. Increasing the diameter of the vessel reduces the volumetric density of the cells and
mitigates local reduction in oxygen concentration. Therefore, an additional control was
created by seeding these larger vessels with a higher concentration of cells, since recent
studies have shown that altering radius of curvature can also dictate cell response [225].
The cell number per unit area was quantified in the following six conditions: (i) 180-µm
static, collagen-only, low seeding density, (ii) 180-µm flow, collagen-only, low seeding
density, (iii) 180-µm static, collagen-HA, low seeding density, (iv) 180-µm flow, collagenHA, low seeding density, (v) 300-µm static, collagen-only, low seeding density, and (vi)
300-µm static, collagen-only, high seeding density. Figures A2A-B show DAPI stains of
the walls of each of these vessels. One-way ANOVA and post-hoc Tukey comparisons
indicated that the 300-µm high density condition had a significantly higher density than
the 300-µm low density condition (Fig. A2C). Images and quantification of DAPI within
collagen/HA hydrogels reveal no significant difference between flow and static conditions
(Supplemental Figure A2). In order to determine whether the difference in cell density also
affected glucose levels, medium removed from the vessels was measured with a glucose
sensor and indicated there was no significant differences between high and low cell density
conditions (Supplemental Figure A3A). An oxygen consumption assay was then conducted
on the cell density representing low density (112,704 cells/well) and high density (175,296
cells/well) as well as a density used in a previous study of HCMEC/D3 oxygen
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consumption that served as a reference value [218], [219]. The consumption rates were
measured to be 6.4 × 10-11 mol/min and 9.6 × 10-11 mol/min for the low and high densities
respectively (Supplemental Figure A3B,C).
The consumption rates were then incorporated into a finite element model as a
reaction term in the diffusion constitutive equation for different cell densities. Figure A2D
shows contour maps of oxygen tension for 180-µm vessels in static and flow conditions
and 300-µm vessels with low and high seeding densities. Supplemental Figure A4
demonstrates that the oxygen gradient is mostly constant along the length of the channel in
the bulk of the hydrogel where measurements were taken. The HA-containing vessels
weren’t modeled since the presence of HA did not significantly affect cell density. The
predicted oxygen tensions surrounding the vessels indicated substantial differences based
on vessel radius and the application of shear stress. As expected, applying flow maintains
the oxygen levels at ambient levels, and the larger diameter vessel mitigates the oxygen
reduction for a given cell density. Figure A2E shows that the high cell density increases
the oxygen deficit in the 300-µm vessel, but not to the level of the 180-µm vessel exposed
to static conditions. Given the large difference in oxygen concentration between the 300µm high density and low density vessels, sprouting density was evaluated in these two
conditions. Figure A2F shows there is substantially more sprouting in the high density
vessel, and one-factor ANOVA reveals that the cell density significantly affects sprouting
percentage (Fig. A2G). Moreover, the 180-µm static vessel, which the finite element model
predicted to have the lowest local oxygen concentrations, had significantly greater
sprouting than both the high and low cell density 300-µm vessels (Supplemental Figure
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A5). Combined with the results presented in Figure A1, these results suggest a direct
correlation between reduced oxygen levels and increased angiogenic response.
III. Differentiating between the effects of oxygen concentration and oxygen gradient
In order to determine whether hypoxia is the driving factor for angiogenesis in the
3D brain microvascular model, 300-µm vessels with low cell seeding density were
incubated in a hypoxic chamber for four days prior to measuring angiogenic sprouting. As
shown in Figure A2F, not only is the oxygen concentration reduced in the conditions
exhibiting increased sprouting, but the oxygen gradient is also increased. Therefore, a
second condition was tested by imposing an external oxygen gradient to the vessel:
oxygenated medium was perfused through the channel adjacent to the endothelialized
channel while the device was in the hypoxic chamber. In order to verify that application of
flow through the acellular channel did not cause interstitial pressure gradients across the
cell-seeded channel, the fluid dynamics were assessed by modeling the collagen gel as a
porous medium [226]. Supplemental Figure A6 indicates that there is a negligible
interstitial pressure gradient caused by perfusion through the acellular channel. Schematics
in Figures A3A,i and A3A,ii display the differences between the hypoxic and oxygen
gradient conditions. Figure A3B shows that minimal sprouting was observed in blood
vessels exposed to a constant 1% O2 environment after 4 days. In contrast, the channels
with the external oxygen gradient exhibited substantial sprouting along the length of the
vessel (Fig. A3C,ii). Quantification revealed that blood vessels in the constant hypoxic
environment exhibited significantly lower sprout percentages compared to the O2 gradient
condition (Fig. A3D). The finite element model provided a means to estimate the difference
in oxygen gradients between conditions. Figure A3E shows contour plots between the
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hypoxic and gradient conditions, and Figure A3F provides quantification of the spatial
oxygen gradient for these two conditions as well as the 300-µm low density vessels in
normoxic conditions. The plot shows that despite the large difference in absolute oxygen
concentrations, there is a negligible difference in the oxygen gradient between normoxic
and hypoxic conditions (~200 mol/m3/m) compared to the imposed gradient, which is
approximately an order of magnitude greater. Overall, these results demonstrate that the
oxygen gradient is the main driving factor for angiogenesis and that the biophysical factors
that affected sprouting, flow and radius of curvature, did so primarily through their effects
on the oxygen gradient experienced by cells lining the vessel.
IV. Evaluating the influence of oxygen gradients on barriergenesis
The importance of oxygen gradient on barrier formation was also evaluated in the
3D brain microvascular model. Previous studies have found that fluid flow is required for
barrier formation, with the assumption that the shear stress exerted by the fluid flow was
the primary factor for barriergenesis. Given the result that fluid flow also altered the oxygen
gradient, the barrier integrity of several conditions with varying angiogenic responses (180µm static with and without HA, 180-µm flow with and without HA, and 300- µm low
density) were evaluated to interrogate any potential correlation between oxygen levels and
tight junction formation. The vessels exposed to static conditions exhibited no significant
difference in either ZO-1 localization to the cell-cell junctions (Figs. A4A-C) or in the
permeability of 4-kDa FITC dextran (Fig. A4D), despite large differences in sprouting
caused by the difference in vessel diameter. Moreover, the 180-µm vessels exposed to flow
exhibited substantially lower vessel permeabilities. There was increased ZO-1 localization
to cell-cell junctions (Figs. A4E-F) and the permeability was significantly lower than the
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static values (Fig. A4G). In contrast to the static conditions, there was a significant
difference between the flow conditions with and without HA: incorporation of HA
significantly reduced the permeability, despite not having any effect on oxygen gradient
and angiogenic sprouting. The ZO-1 images and permeability assays are consistent with
previous results showing that CD44 mediates shear stress mechanotransduction through
small GTPases such as RhoA and Rac1 to induce barriergenesis in cerebral vasculature
[186]. Moreover, ZO-1 was present in the sprouts from both static and flow conditions, but
it was not localized to the cell-cell junctions in either condition (Supplemental Figure A7).
This result is consistent with the permeability measurements, since parent vessels did not
exhibit barrier function in the static condition and there were no lumens observed in the
sprouts from parent vessels exposed to flow. Overall, these results demonstrate no
correlation between oxygen gradient and barrier integrity and supports the hypothesis that
the mechanical stress exerted by fluid flow is the primary factor driving barrier formation
in the 3D brain microvascular model. Taken together with the data presented in Figure A1
that vessels exposed to flow exhibit a non-zero level of angiogenic sprouting, these results
suggest that the mechanisms dictating angiogenesis and barriergenesis are independent
from one another and sprouting does not compromise the barrier.
Discussion
The combination of experimental and computational results presented here identify
the spatial oxygen gradient as the primary instigating factor for angiogenic sprouting in
cerebral vasculature among the biophysical parameters evaluated here: matrix
composition, fluid shear stress, and vessel diameter. The relationship between oxygen
concentration and angiogenesis has been cited frequently, especially in the context of tumor
formation where hypoxia and formation of neovessels are spatially correlated. However,
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there is ample evidence that the connection between oxygen concentration and
angiogenesis may be more complex than a direct causal link: previous studies have shown
that hypoxia does not always correlate to the growth of new blood vessels from existing
vasculature [227]. Several tissues including the myocardium [228] and visual cortex [229]
have baseline, physiologic hypoxia that do not induce angiogenesis. Moreover, there are
processes like wound healing where hypoxia is a byproduct of angiogenesis, not a driving
factor [227]. The in vitro 3D brain microvascular model presents a means to directly
evaluate the effect of hypoxia in cerebral vasculature, and it demonstrated no significant
difference in sprouting between normoxic conditions and an environment with 1% oxygen.
In contrast, imposing an external oxygen gradient by perfusing oxygenated medium
through an adjacent channel in low oxygen ambient conditions significantly increased
angiogenic sprouting. Taken together, these results show that simply decreasing the oxygen
levels does not lead to activation of endothelial cells, but rather the presence of a gradient
may lead to angiogenesis.
Further studies are required to clarify whether the effect of oxygen gradient on
angiogenesis is unique to the central nervous system. Endothelial cells in the brain have
unique properties, including the formation of tight junctions that give rise to the bloodbrain barrier. Their metabolic activities also differ from other regions of the body, and
therefore these cells may respond to oxygen levels differently from their counterparts in
other organs. There are several pathologies where large oxygen gradients are present within
the central nervous system, and these scenarios are characterized by rapid angiogenesis.
For example, the formation of glioblastoma (GBM) creates large spatial gradients of
oxygen between the tumor and surrounding parenchyma, and GBM exhibits substantial
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growth of new vessels from the existing vasculature [36–37]. Moreover, following spinal
cord injury there is a strong and temporary angiogenic response that precedes the formation
of a glial scar [36], and the site of injury is characterized by hypoxia due to disruption of
the blood supply. The result that oxygen gradient is the primary driving factor for
angiogenesis in the central nervous system is consistent with these pathologies. There are
several examples of pathologies outside the central nervous system, including tumor
formation and wound healing, that suggest the effect of oxygen gradient is universal. In
vitro vascular models provide a means to evaluate the relationship between spatial
differences in oxygen levels and angiogenesis in other organ systems.
The effect of oxygen gradients on barrier formation was also evaluated, given the
ability of cerebral endothelial cells to form tight junctions. In contrast to angiogenesis,
there did not appear to be a correlation between oxygen gradient and the barrier integrity
of the 3D vessels. Both the low density, 300-µm diameter vessel cultured in static
conditions and the 180-µm diameter vessel perfused with 0.7 dyn/cm2 of shear stress
exhibited the two lowest oxygen gradients of the conditions tested, and these conditions
had significantly different permeabilities and localization of ZO-1 to cell-cell junctions. As
shown in a previous version of this 3D blood-brain barrier model [124], the main driving
factor for barrier formation is the shear stress exerted on the endothelium by fluid flow,
and these results are consistent with that finding. These studies indicate that different
stimuli and likely different signaling pathways mediate barrier formation and angiogenic
sprouting. Given that the vessels exposed to flow exhibited some level of sprouting, though
significantly less than other conditions, the two processes of barrier formation and
angiogenesis may occur simultaneously. In fact, a recent study using transgenic zebrafish
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with promoters for barrier development demonstrated that angiogenesis and barriergenesis
occur at the same time within the central nervous system [203]. Additional studies are
required to understand the interdependence, or lack thereof, of signaling pathways
mediating these two processes.
The results of the study do not preclude the importance of other pro-angiogenic
factors unrelated to the spatial oxygen gradient. Although non-cerebral endothelial cells
were used, previous in vitro models have identified the growth factors most likely to
stimulate sprouting from an endothelialized vessel [204]. Small GTPases like cdc42 that
contribute to sprouting are activated by specific agonists and not differences in oxygen
concentration [205]. Furthermore, previous studies have shown that fluid shear stress, if
applied with a sufficiently high magnitude, can induce sprouting from HUVEC-lined
channels with diameters of 400-µm [127]. Augmenting shear stress by increasing flow rate
does not exacerbate the oxygen gradient experienced by the cells within the vessel,
suggesting that the mechanical stimulus is responsible for instigating angiogenesis.
Overall, there are likely several biophysical and biochemical factors that cause sprouting
independent of local oxygen levels. Nonetheless, the studies presented here reveal that
oxygen gradient is more important than overall oxygen concentration for driving
angiogenesis.
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Figure A1. 180-μm blood vessels exposed to (A) static and (B) flow conditions after 4
days in culture. Angiogenic sprouts from 180-μm parent blood vessels fabricated in
(C,D) collagen and (E,F) collagen/HA hydrogels on day 4. (Ci,Ei) Blood vessels
incubated in static conditions and (Di,Fi) vessels exposed to fluid flow. (ii) Confocal
microscopy stacks of the YZ plane showing the presence of sprout lumens (white
arrows). Purple dotted lines in C-F indicate the region of cross-section used for
orthogonal views to identify the presence of luminal space within the angiogenic
sprouts. E) Sprouting percentage of the 4 conditions. DAPI = blue and F-actin = green.
Scale = 100 μm. The box plots depict the median, 25 and 75 percentiles, and the
whiskers represent 1.5x the interquartile range. *p < 0.05 (n = 3).
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Figure A2. Confocal images of DAPI stains verifying cells per area in (A) 180-μm
seeded with 5 × 106 cells/mL in collagen-only hydrogels exposed to (i) static and (ii)
flow conditions and (B) 300-μm collagen-only hydrogels seeded with (i) 5 × 106
cells/mL and (ii) 20 × 106 cells/mL. (C) Quantification of nuclei per cm2. (D)
Computational models of oxygen consumption in each vessel conditions. Scale = 100
μm. (E) Oxygen levels dependent on distance from vessels, y-axis range is 8.5-9.5
mol/m3. (F) Immunofluorescence images of angiogenic sprouts in 300-μm seeded with
(i) 5 × 106 cells/mL and (ii) 20 × 106 cells/mL. (G) Sprouting percentage of these
conditions. DAPI = blue and F-actin = green. Scale = 50 μm. The box plots depict the
median, 25 and 75 percentiles, and the whiskers represent 1.5x the interquartile range.
*p < 0.05 (n = 3).
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Figure A3. Schematic of blood vessels in static conditions incubated in a hypoxic and
oxygen gradient environment. Confocal images of angiogenic sprouts in 300-μm
vessels seeded with 5 × 106 cells/mL exposed to (B) hypoxia and (C) O2 gradient. (D)
Quantification of sprout percentage. (E) Computational models of oxygen
concentration in each vessel conditions. (F) Oxygen levels dependent on distance from
vessels. DAPI = blue and F-actin = red. Scale = 100 μm. The box plots depict the
median, 25 and 75 percentiles, and the whiskers represent 1.5x the interquartile range.
*p < 0.05 (n = 3).
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Figure A4. (A-C) Confocal stacks of blood vessels cultured in static conditions and (EF) flow conditions labeled with (i) DAPI (blue), FITC-phalloidin (green), and (ii) ZO1 (red). Permeability quantification of vessels exposed to (D) static and (G) luminal
shear stress for 4 days measured with 4kDa dextran. Scale = 50 μm. The box plots
depict the median, 25 and 75 percentiles, and the whiskers represent 1.5x the
interquartile range. *p < 0.05 (n = 3).
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Supplemental Figure A1. Computational model methods. (A) Schematic of
microfluidic device showing the location of the hydrogel for the computational model.
(B) A mesh showing cell-seeded and acellular channels. (C) Parameters for the
COMSOL models.

Supplemental Figure A2. DAPI stains verifying cells per area in collagen/HA
hydrogels exposed to (Ai) static and (Aii) flow conditions. (B) Quantification of DAPI
per cm2. DAPI = blue. Scale = 100 μm. *p < 0.05 (n = 3).
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Supplemental Figure A3. (A) Glucose concentrations within the 300 μm low cell and
high cell density vessels. (B) Representative lifetime signal from oxygen
phosphorescent probe from each condition. (C) Oxygen consumption rates for low cell
and high cell density conditions.

Supplemental Figure A4. (A) Oxygen concentration along the length of 3D brain
microvascular model. (B) Concentration profile along the channel.
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Supplemental Figure A5. Box plot comparing sprout percentage between 180 μm and
300 μm blood vessels in collagen hydrogels. *p < 0.05 (n = 3).
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Supplemental Figure A6. Computational model of interstitial pressure gradients in
collagen hydrogels showing (A) pressure in a porous medium and (B) velocity from the
adjacent acellular channel.
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Supplemental Figure A7. ZO-1 in angiogenic sprouts in (A) static and (B) flow
conditions. DAPI = blue, F-actin = green, ZO-1 = red. Scale = 15 μm.
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